This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3

• Using Codes
• Code Systems
• Value Sets
• Concept Maps
• Identifier Systems

4.4.2.16226 HL7 v3 Value Set ObservationType

Vocabulary Work Group

Maturity Level: N/A

External

Use Context: Any

This value set (http://terminology.hl7.org/ValueSet/v3-ObservationType) is defined as part of HL7 v3.

Summary

This value set is not currently used

4.4.2.16226.1 Content Logical Definition

4.4.2.16226.2 Expansion

This expansion generated 03 May 2020

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

Expansion based on v3 Code System ActCode v2019-07-31 (CodeSystem)

Code	System	Display	Logical Definition (CLD)
_ObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	ObservationType	Identifies the kinds of observations that can be performed
_ActSpecObsCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActSpecObsCode	Identifies the type of observation that is made about a specimen that may affect its processing, analysis or further result interpretation
ARTBLD	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActSpecObsArtBldCode	Describes the artificial blood identifier that is associated with the specimen.
DILUTION	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActSpecObsDilutionCode	An observation that reports the dilution of a sample.
AUTO-HIGH	http://terminology.hl7.org/CodeSystem/v3-ActCode	Auto-High Dilution	The dilution of a sample performed by automated equipment. The value is specified by the equipment
AUTO-LOW	http://terminology.hl7.org/CodeSystem/v3-ActCode	Auto-Low Dilution	The dilution of a sample performed by automated equipment. The value is specified by the equipment
PRE	http://terminology.hl7.org/CodeSystem/v3-ActCode	Pre-Dilution	The dilution of the specimen made prior to being loaded onto analytical equipment
RERUN	http://terminology.hl7.org/CodeSystem/v3-ActCode	Rerun Dilution	The value of the dilution of a sample after it had been analyzed at a prior dilution value
EVNFCTS	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActSpecObsEvntfctsCode	Domain provides codes that qualify the ActLabObsEnvfctsCode domain. (Environmental Factors)
INTFR	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActSpecObsInterferenceCode	An observation that relates to factors that may potentially cause interference with the observation
FIBRIN	http://terminology.hl7.org/CodeSystem/v3-ActCode	Fibrin	The Fibrin Index of the specimen. In the case of only differentiating between Absent and Present, recommend using 0 and 1
HEMOLYSIS	http://terminology.hl7.org/CodeSystem/v3-ActCode	Hemolysis	An observation of the hemolysis index of the specimen in g/L
ICTERUS	http://terminology.hl7.org/CodeSystem/v3-ActCode	Icterus	An observation that describes the icterus index of the specimen. It is recommended to use mMol/L of bilirubin
LIPEMIA	http://terminology.hl7.org/CodeSystem/v3-ActCode	Lipemia	An observation used to describe the Lipemia Index of the specimen. It is recommended to use the optical turbidity at 600 nm (in absorbance units).
VOLUME	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActSpecObsVolumeCode	An observation that reports the volume of a sample.
AVAILABLE	http://terminology.hl7.org/CodeSystem/v3-ActCode	Available Volume	The available quantity of specimen. This is the current quantity minus any planned consumption (e.g., tests that are planned)
CONSUMPTION	http://terminology.hl7.org/CodeSystem/v3-ActCode	Consumption Volume	The quantity of specimen that is used each time the equipment uses this substance
CURRENT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Current Volume	The current quantity of the specimen, i.e., initial quantity minus what has been actually used.
INITIAL	http://terminology.hl7.org/CodeSystem/v3-ActCode	Initial Volume	The initial quantity of the specimen in inventory
_AnnotationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	AnnotationType	AnnotationType
_ActPatientAnnotationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActPatientAnnotationType	Description:Provides a categorization for annotations recorded directly against the patient .
ANNDI	http://terminology.hl7.org/CodeSystem/v3-ActCode	diagnostic image note	Description:A note that is specific to a patient's diagnostic images, either historical, current or planned.
ANNGEN	http://terminology.hl7.org/CodeSystem/v3-ActCode	general note	Description:A general or uncategorized note.
ANNIMM	http://terminology.hl7.org/CodeSystem/v3-ActCode	immunization note	A note that is specific to a patient's immunizations, either historical, current or planned.
ANNLAB	http://terminology.hl7.org/CodeSystem/v3-ActCode	laboratory note	Description:A note that is specific to a patient's laboratory results, either historical, current or planned.
ANNMED	http://terminology.hl7.org/CodeSystem/v3-ActCode	medication note	Description:A note that is specific to a patient's medications, either historical, current or planned.
_GeneticObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	GeneticObservationType	Description: None provided
GENE	http://terminology.hl7.org/CodeSystem/v3-ActCode	gene	Description: A DNA segment that contributes to phenotype/function. In the absence of demonstrated function a gene may be characterized by sequence, transcription or homology
_ImmunizationObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	ImmunizationObservationType	Description: Observation codes which describe characteristics of the immunization material.
OBSANTC	http://terminology.hl7.org/CodeSystem/v3-ActCode	antigen count	Description: Indicates the valid antigen count.
OBSANTV	http://terminology.hl7.org/CodeSystem/v3-ActCode	antigen validity	Description: Indicates whether an antigen is valid or invalid.
_IndividualCaseSafetyReportType	http://terminology.hl7.org/CodeSystem/v3-ActCode	Individual Case Safety Report Type	A code that is used to indicate the type of case safety report received from sender. The current code example reference is from the International Conference on Harmonisation (ICH) Expert Workgroup guideline on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports. The unknown/unavailable option allows the transmission of information from a secondary sender where the initial sender did not specify the type of report. Example concepts include: Spontaneous, Report from study, Other.
PAT_ADV_EVNT	http://terminology.hl7.org/CodeSystem/v3-ActCode	patient adverse event	Indicates that the ICSR is describing problems that a patient experienced after receiving a vaccine product.
VAC_PROBLEM	http://terminology.hl7.org/CodeSystem/v3-ActCode	vaccine product problem	Indicates that the ICSR is describing a problem with the actual vaccine product such as physical defects (cloudy, particulate matter) or inability to confer immunity.
_LOINCObservationActContextAgeType	http://terminology.hl7.org/CodeSystem/v3-ActCode	LOINCObservationActContextAgeType	Definition:The set of LOINC codes for the act of determining the period of time that has elapsed since an entity was born or created.
21611-9	http://terminology.hl7.org/CodeSystem/v3-ActCode	age patient qn est	Definition:Estimated age.
21612-7	http://terminology.hl7.org/CodeSystem/v3-ActCode	age patient qn reported	Definition:Reported age.
29553-5	http://terminology.hl7.org/CodeSystem/v3-ActCode	age patient qn calc	Definition:Calculated age.
30525-0	http://terminology.hl7.org/CodeSystem/v3-ActCode	age patient qn definition	Definition:General specification of age with no implied method of determination.
30972-4	http://terminology.hl7.org/CodeSystem/v3-ActCode	age at onset of adverse event	Definition:Age at onset of associated adverse event; no implied method of determination.
_MedicationObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	MedicationObservationType	MedicationObservationType
REP_HALF_LIFE	http://terminology.hl7.org/CodeSystem/v3-ActCode	representative half-life	Description:This observation represents an 'average' or 'expected' half-life typical of the product.
SPLCOATING	http://terminology.hl7.org/CodeSystem/v3-ActCode	coating	Definition: A characteristic of an oral solid dosage form of a medicinal product, indicating whether it has one or more coatings such as sugar coating, film coating, or enteric coating. Only coatings to the external surface or the dosage form should be considered (for example, coatings to individual pellets or granules inside a capsule or tablet are excluded from consideration). Constraints: The Observation.value must be a Boolean (BL) with true for the presence or false for the absence of one or more coatings on a solid dosage form.
SPLCOLOR	http://terminology.hl7.org/CodeSystem/v3-ActCode	color	Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the color or colors that most predominantly define the appearance of the dose form. SPLCOLOR is not an FDA specification for the actual color of solid dosage forms or the names of colors that can appear in labeling. Constraints: The Observation.value must be a single coded value or a list of multiple coded values, specifying one or more distinct colors that approximate of the color(s) of distinct areas of the solid dosage form, such as the different sides of a tablet or one-part capsule, or the different halves of a two-part capsule. Bands on banded capsules, regardless of the color, are not considered when assigning an SPLCOLOR. Imprints on the dosage form, regardless of their color are not considered when assigning an SPLCOLOR. If more than one color exists on a particular side or half, then the most predominant color on that side or half is recorded. If the gelatin capsule shell is colorless and transparent, use the predominant color of the contents that appears through the colorless and transparent capsule shell. Colors can include: Black;Gray;White;Red;Pink;Purple;Green;Yellow;Orange;Brown;Blue;Turquoise.
SPLIMAGE	http://terminology.hl7.org/CodeSystem/v3-ActCode	image	Description: A characteristic representing a single file reference that contains two or more views of the same dosage form of the product; in most cases this should represent front and back views of the dosage form, but occasionally additional views might be needed in order to capture all of the important physical characteristics of the dosage form. Any imprint and/or symbol should be clearly identifiable, and the viewer should not normally need to rotate the image in order to read it. Images that are submitted with SPL should be included in the same directory as the SPL file.
SPLIMPRINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	imprint	Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the alphanumeric text that appears on the solid dosage form, including text that is embossed, debossed, engraved or printed with ink. The presence of other non-textual distinguishing marks or symbols is recorded by SPLSYMBOL. Examples: Included in SPLIMPRINT are alphanumeric text that appears on the bands of banded capsules and logos and other symbols that can be interpreted as letters or numbers. Constraints: The Observation.value must be of type Character String (ST). Excluded from SPLIMPRINT are internal and external cut-outs in the form of alphanumeric text and the letter 'R' with a circle around it (when referring to a registered trademark) and the letters 'TM' (when referring to a 'trade mark'). To record text, begin on either side or part of the dosage form. Start at the top left and progress as one would normally read a book. Enter a semicolon to show separation between words or line divisions.
SPLSCORING	http://terminology.hl7.org/CodeSystem/v3-ActCode	scoring	Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the number of equal pieces that the solid dosage form can be divided into using score line(s). Example: One score line creating two equal pieces is given a value of 2, two parallel score lines creating three equal pieces is given a value of 3. Constraints: Whether three parallel score lines create four equal pieces or two intersecting score lines create two equal pieces using one score line and four equal pieces using both score lines, both have the scoring value of 4. Solid dosage forms that are not scored are given a value of 1. Solid dosage forms that can only be divided into unequal pieces are given a null-value with nullFlavor other (OTH).
SPLSHAPE	http://terminology.hl7.org/CodeSystem/v3-ActCode	shape	Description: A characteristic of an oral solid dosage form of a medicinal product, specifying the two dimensional representation of the solid dose form, in terms of the outside perimeter of a solid dosage form when the dosage form, resting on a flat surface, is viewed from directly above, including slight rounding of corners. SPLSHAPE does not include embossing, scoring, debossing, or internal cut-outs. SPLSHAPE is independent of the orientation of the imprint and logo. Shapes can include: Triangle (3 sided); Square; Round; Semicircle; Pentagon (5 sided); Diamond; Double circle; Bullet; Hexagon (6 sided); Rectangle; Gear; Capsule; Heptagon (7 sided); Trapezoid; Oval; Clover; Octagon (8 sided); Tear; Freeform.
SPLSIZE	http://terminology.hl7.org/CodeSystem/v3-ActCode	size	Definition: A characteristic of an oral solid dosage form of a medicinal product, specifying the longest single dimension of the solid dosage form as a physical quantity in the dimension of length (e.g., 3 mm). The length is should be specified in millimeters and should be rounded to the nearest whole millimeter. Example: SPLSIZE for a rectangular shaped tablet is the length and SPLSIZE for a round shaped tablet is the diameter.
SPLSYMBOL	http://terminology.hl7.org/CodeSystem/v3-ActCode	symbol	Definition: A characteristic of an oral solid dosage form of a medicinal product, to describe whether or not the medicinal product has a mark or symbol appearing on it for easy and definite recognition. Score lines, letters, numbers, and internal and external cut-outs are not considered marks or symbols. See SPLSCORING and SPLIMPRINT for these characteristics. Constraints: The Observation.value must be a Boolean (BL) with <u>true</u> indicating the presence and <u>false</u> for the absence of marks or symbols. Example:
_ObservationIssueTriggerCodedObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	ObservationIssueTriggerCodedObservationType	Distinguishes the kinds of coded observations that could be the trigger for clinical issue detection. These are observations that are not measurable, but instead can be defined with codes. Coded observation types include: Allergy, Intolerance, Medical Condition, Pregnancy status, etc.
_CaseTransmissionMode	http://terminology.hl7.org/CodeSystem/v3-ActCode	case transmission mode	Code for the mechanism by which disease was acquired by the living subject involved in the public health case. Includes sexually transmitted, airborne, bloodborne, vectorborne, foodborne, zoonotic, nosocomial, mechanical, dermal, congenital, environmental exposure, indeterminate.
AIRTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	airborne transmission	Communication of an agent from a living subject or environmental source to a living subject through indirect contact via oral or nasal inhalation.
ANANTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	animal to animal transmission	Communication of an agent from one animal to another proximate animal.
ANHUMTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	animal to human transmission	Communication of an agent from an animal to a proximate person.
BDYFLDTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	body fluid contact transmission	Communication of an agent from one living subject to another living subject through direct contact with any body fluid.
BLDTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	blood borne transmission	Communication of an agent to a living subject through direct contact with blood or blood products whether the contact with blood is part of a therapeutic procedure or not.
DERMTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	transdermal transmission	Communication of an agent from a living subject or environmental source to a living subject via agent migration through intact skin.
ENVTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	environmental exposure transmission	Communication of an agent from an environmental surface or source to a living subject by direct contact.
FECTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	fecal-oral transmission	Communication of an agent from a living subject or environmental source to a living subject through oral contact with material contaminated by person or animal fecal material.
FOMTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	fomite transmission	Communication of an agent from an non-living material to a living subject through direct contact.
FOODTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	food-borne transmission	Communication of an agent from a food source to a living subject via oral consumption.
HUMHUMTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	human to human transmission	Communication of an agent from a person to a proximate person.
INDTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	indeterminate disease transmission mode	Communication of an agent to a living subject via an undetermined route.
LACTTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	lactation transmission	Communication of an agent from one living subject to another living subject through direct contact with mammalian milk or colostrum.
NOSTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	nosocomial transmission	Communication of an agent from any entity to a living subject while the living subject is in the patient role in a healthcare facility.
PARTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	parenteral transmission	Communication of an agent from a living subject or environmental source to a living subject where the acquisition of the agent is not via the alimentary canal.
PLACTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	transplacental transmission	Communication of an agent from a living subject to the progeny of that living subject via agent migration across the maternal-fetal placental membranes while in utero.
SEXTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	sexual transmission	Communication of an agent from one living subject to another living subject through direct contact with genital or oral tissues as part of a sexual act.
TRNSFTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	transfusion transmission	Communication of an agent from one living subject to another living subject through direct contact with blood or blood products where the contact with blood is part of a therapeutic procedure.
VECTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	vector-borne transmission	Communication of an agent from a living subject acting as a required intermediary in the agent transmission process to a recipient living subject via direct contact.
WATTRNS	http://terminology.hl7.org/CodeSystem/v3-ActCode	water-borne transmission	Communication of an agent from a contaminated water source to a living subject whether the water is ingested as a food or not. The route of entry of the water may be through any bodily orifice.
_ObservationQualityMeasureAttribute	http://terminology.hl7.org/CodeSystem/v3-ActCode	ObservationQualityMeasureAttribute	Codes used to define various metadata aspects of a health quality measure.
AGGREGATE	http://terminology.hl7.org/CodeSystem/v3-ActCode	aggregate measure observation	Indicates that the observation is carrying out an aggregation calculation, contained in the value element.
CMPMSRMTH	http://terminology.hl7.org/CodeSystem/v3-ActCode	composite measure method	Indicates what method is used in a quality measure to combine the component measure results included in an composite measure.
CMPMSRSCRWGHT	http://terminology.hl7.org/CodeSystem/v3-ActCode	component measure scoring weight	An attribute of a quality measure describing the weight this component measure score is to carry in determining the overall composite measure final score. The value is real value greater than 0 and less than 1.0. Each component measure score will be multiplied by its CMPMSRSCRWGHT and then summed with the other component measures to determine the final overall composite measure score. The sum across all CMPMSRSCRWGHT values within a single composite measure SHALL be 1.0. The value assigned is scoped to the composite measure referencing this component measure only.
COPY	http://terminology.hl7.org/CodeSystem/v3-ActCode	copyright	Identifies the organization(s) who own the intellectual property represented by the eMeasure.
CRS	http://terminology.hl7.org/CodeSystem/v3-ActCode	clinical recommendation statement	Summary of relevant clinical guidelines or other clinical recommendations supporting this eMeasure.
DEF	http://terminology.hl7.org/CodeSystem/v3-ActCode	definition	Description of individual terms, provided as needed.
DISC	http://terminology.hl7.org/CodeSystem/v3-ActCode	disclaimer	Disclaimer information for the eMeasure.
FINALDT	http://terminology.hl7.org/CodeSystem/v3-ActCode	finalized date/time	The timestamp when the eMeasure was last packaged in the Measure Authoring Tool.
GUIDE	http://terminology.hl7.org/CodeSystem/v3-ActCode	guidance	Used to allow measure developers to provide additional guidance for implementers to understand greater specificity than could be provided in the logic for data criteria.
IDUR	http://terminology.hl7.org/CodeSystem/v3-ActCode	improvement notation	Information on whether an increase or decrease in score is the preferred result (e.g., a higher score indicates better quality OR a lower score indicates better quality OR quality is within a range).
ITMCNT	http://terminology.hl7.org/CodeSystem/v3-ActCode	items counted	Describes the items counted by the measure (e.g., patients, encounters, procedures, etc.)
KEY	http://terminology.hl7.org/CodeSystem/v3-ActCode	keyword	A significant word that aids in discoverability.
MEDT	http://terminology.hl7.org/CodeSystem/v3-ActCode	measurement end date	The end date of the measurement period.
MSD	http://terminology.hl7.org/CodeSystem/v3-ActCode	measurement start date	The start date of the measurement period.
MSRADJ	http://terminology.hl7.org/CodeSystem/v3-ActCode	risk adjustment	The method of adjusting for clinical severity and conditions present at the start of care that can influence patient outcomes for making valid comparisons of outcome measures across providers. Indicates whether an eMeasure is subject to the statistical process for reducing, removing, or clarifying the influences of confounding factors to allow more useful comparisons.
MSRAGG	http://terminology.hl7.org/CodeSystem/v3-ActCode	rate aggregation	Describes how to combine information calculated based on logic in each of several populations into one summarized result. It can also be used to describe how to risk adjust the data based on supplemental data elements described in the eMeasure. (e.g., pneumonia hospital measures antibiotic selection in the ICU versus non-ICU and then the roll-up of the two). Open Issue: The description does NOT align well with the definition used in the HQMF specfication; correct the MSGAGG definition, and the possible distinction of MSRAGG as a child of AGGREGATE.
MSRIMPROV	http://terminology.hl7.org/CodeSystem/v3-ActCode	health quality measure improvement notation	Information on whether an increase or decrease in score is the preferred result. This should reflect information on which way is better, an increase or decrease in score.
MSRJUR	http://terminology.hl7.org/CodeSystem/v3-ActCode	jurisdiction	The list of jurisdiction(s) for which the measure applies.
MSRRPTR	http://terminology.hl7.org/CodeSystem/v3-ActCode	reporter type	Type of person or organization that is expected to report the issue.
MSRRPTTIME	http://terminology.hl7.org/CodeSystem/v3-ActCode	timeframe for reporting	The maximum time that may elapse following completion of the measure until the measure report must be sent to the receiver.
MSRSCORE	http://terminology.hl7.org/CodeSystem/v3-ActCode	measure scoring	Indicates how the calculation is performed for the eMeasure (e.g., proportion, continuous variable, ratio)
MSRSET	http://terminology.hl7.org/CodeSystem/v3-ActCode	health quality measure care setting	Location(s) in which care being measured is rendered Usage Note: MSRSET is used rather than RoleCode because the setting applies to what is being measured, as opposed to participating directly in the health quality measure documantion itself).
MSRTOPIC	http://terminology.hl7.org/CodeSystem/v3-ActCode	health quality measure topic type	health quality measure topic type
MSRTP	http://terminology.hl7.org/CodeSystem/v3-ActCode	measurement period	The time period for which the eMeasure applies.
MSRTYPE	http://terminology.hl7.org/CodeSystem/v3-ActCode	measure type	Indicates whether the eMeasure is used to examine a process or an outcome over time (e.g., Structure, Process, Outcome).
RAT	http://terminology.hl7.org/CodeSystem/v3-ActCode	rationale	Succinct statement of the need for the measure. Usually includes statements pertaining to Importance criterion: impact, gap in care and evidence.
REF	http://terminology.hl7.org/CodeSystem/v3-ActCode	reference	Identifies bibliographic citations or references to clinical practice guidelines, sources of evidence, or other relevant materials supporting the intent and rationale of the eMeasure.
SDE	http://terminology.hl7.org/CodeSystem/v3-ActCode	supplemental data elements	Comparison of results across strata can be used to show where disparities exist or where there is a need to expose differences in results. For example, Centers for Medicare & Medicaid Services (CMS) in the U.S. defines four required Supplemental Data Elements (payer, ethnicity, race, and gender), which are variables used to aggregate data into various subgroups. Additional supplemental data elements required for risk adjustment or other purposes of data aggregation can be included in the Supplemental Data Element section.
STRAT	http://terminology.hl7.org/CodeSystem/v3-ActCode	stratification	Describes the strata for which the measure is to be evaluated. There are three examples of reasons for stratification based on existing work. These include: (1) evaluate the measure based on different age groupings within the population described in the measure (e.g., evaluate the whole [age 14-25] and each sub-stratum [14-19] and [20-25]); (2) evaluate the eMeasure based on either a specific condition, a specific discharge location, or both; (3) evaluate the eMeasure based on different locations within a facility (e.g., evaluate the overall rate for all intensive care units and also some strata include additional findings [specific birth weights for neonatal intensive care units]).
TRANF	http://terminology.hl7.org/CodeSystem/v3-ActCode	transmission format	Can be a URL or hyperlinks that link to the transmission formats that are specified for a particular reporting program.
USE	http://terminology.hl7.org/CodeSystem/v3-ActCode	notice of use	Usage notes.
_ObservationSequenceType	http://terminology.hl7.org/CodeSystem/v3-ActCode	ObservationSequenceType	ObservationSequenceType
TIME_ABSOLUTE	http://terminology.hl7.org/CodeSystem/v3-ActCode	absolute time sequence	A sequence of values in the "absolute" time domain. This is the same time domain that all HL7 timestamps use. It is time as measured by the Gregorian calendar
TIME_RELATIVE	http://terminology.hl7.org/CodeSystem/v3-ActCode	relative time sequence	A sequence of values in a "relative" time domain. The time is measured relative to the earliest effective time in the Observation Series containing this sequence.
_ObservationSeriesType	http://terminology.hl7.org/CodeSystem/v3-ActCode	ObservationSeriesType	ObservationSeriesType
_ECGObservationSeriesType	http://terminology.hl7.org/CodeSystem/v3-ActCode	ECGObservationSeriesType	ECGObservationSeriesType
REPRESENTATIVE_BEAT	http://terminology.hl7.org/CodeSystem/v3-ActCode	ECG representative beat waveforms	This Observation Series type contains waveforms of a "representative beat" (a.k.a. "median beat" or "average beat"). The waveform samples are measured in relative time, relative to the beginning of the beat as defined by the Observation Series effective time. The waveforms are not directly acquired from the subject, but rather algorithmically derived from the "rhythm" waveforms.
RHYTHM	http://terminology.hl7.org/CodeSystem/v3-ActCode	ECG rhythm waveforms	This Observation type contains ECG "rhythm" waveforms. The waveform samples are measured in absolute time (a.k.a. "subject time" or "effective time"). These waveforms are usually "raw" with some minimal amount of noise reduction and baseline filtering applied.
_PatientImmunizationRelatedObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	PatientImmunizationRelatedObservationType	Description: Reporting codes that are related to an immunization event.
CLSSRM	http://terminology.hl7.org/CodeSystem/v3-ActCode	classroom	Description: The class room associated with the patient during the immunization event.
GRADE	http://terminology.hl7.org/CodeSystem/v3-ActCode	grade	Description: The school grade or level the patient was in when immunized.
SCHL	http://terminology.hl7.org/CodeSystem/v3-ActCode	school	Description: The school the patient attended when immunized.
SCHLDIV	http://terminology.hl7.org/CodeSystem/v3-ActCode	school division	Description: The school division or district associated with the patient during the immunization event.
TEACHER	http://terminology.hl7.org/CodeSystem/v3-ActCode	teacher	Description: The patient's teacher when immunized.
_PopulationInclusionObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	PopulationInclusionObservationType	Observation types for specifying criteria used to assert that a subject is included in a particular population.
DENEX	http://terminology.hl7.org/CodeSystem/v3-ActCode	denominator exclusions	Criteria which specify subjects who should be removed from the eMeasure population and denominator before determining if numerator criteria are met. Denominator exclusions are used in proportion and ratio measures to help narrow the denominator.
DENEXCEP	http://terminology.hl7.org/CodeSystem/v3-ActCode	denominator exceptions	Criteria which specify the removal of a subject, procedure or unit of measurement from the denominator, only if the numerator criteria are not met. Denominator exceptions allow for adjustment of the calculated score for those providers with higher risk populations. Denominator exceptions are used only in proportion eMeasures. They are not appropriate for ratio or continuous variable eMeasures. Denominator exceptions allow for the exercise of clinical judgment and should be specifically defined where capturing the information in a structured manner fits the clinical workflow. Generic denominator exception reasons used in proportion eMeasures fall into three general categories: Medical reasons Patient (or subject) reasons System reasons
DENOM	http://terminology.hl7.org/CodeSystem/v3-ActCode	denominator	Criteria for specifying the entities to be evaluated by a specific quality measure, based on a shared common set of characteristics (within a specific measurement set to which a given measure belongs). The denominator can be the same as the initial population, or it may be a subset of the initial population to further constrain it for the purpose of the eMeasure. Different measures within an eMeasure set may have different denominators. Continuous Variable eMeasures do not have a denominator, but instead define a measure population.
IPOP	http://terminology.hl7.org/CodeSystem/v3-ActCode	initial population	Criteria for specifying the entities to be evaluated by a specific quality measure, based on a shared common set of characteristics (within a specific measurement set to which a given measure belongs).
IPPOP	http://terminology.hl7.org/CodeSystem/v3-ActCode	initial patient population	Criteria for specifying the patients to be evaluated by a specific quality measure, based on a shared common set of characteristics (within a specific measurement set to which a given measure belongs). Details often include information based upon specific age groups, diagnoses, diagnostic and procedure codes, and enrollment periods.
MSROBS	http://terminology.hl7.org/CodeSystem/v3-ActCode	measure observation	Defines the observation to be performed for each patient or event in the measure population. Measure observations for each case in the population are aggregated to determine the overall measure score for the population. Examples: the median time from arrival in the Emergency Room to departure the median time from decision to admit to a hospital to the actual admission for Emergency Room patients
MSRPOPL	http://terminology.hl7.org/CodeSystem/v3-ActCode	measure population	Criteria for specifying the measure population as a narrative description (e.g., all patients seen in the Emergency Department during the measurement period). This is used only in continuous variable eMeasures.
MSRPOPLEX	http://terminology.hl7.org/CodeSystem/v3-ActCode	measure population exclusions	Criteria for specifying subjects who should be removed from the eMeasure's Initial Population and Measure Population. Measure Population Exclusions are used in Continuous Variable measures to help narrow the Measure Population before determining the value(s) of the continuous variable(s).
NUMER	http://terminology.hl7.org/CodeSystem/v3-ActCode	numerator	Criteria for specifying the processes or outcomes expected for each patient, procedure, or other unit of measurement defined in the denominator for proportion measures, or related to (but not directly derived from) the denominator for ratio measures (e.g., a numerator listing the number of central line blood stream infections and a denominator indicating the days per thousand of central line usage in a specific time period).
NUMEX	http://terminology.hl7.org/CodeSystem/v3-ActCode	numerator exclusions	Criteria for specifying instances that should not be included in the numerator data. (e.g., if the number of central line blood stream infections per 1000 catheter days were to exclude infections with a specific bacterium, that bacterium would be listed as a numerator exclusion). Numerator Exclusions are used only in ratio eMeasures.
_PreferenceObservationType	http://terminology.hl7.org/CodeSystem/v3-ActCode	_PreferenceObservationType	Types of observations that can be made about Preferences.
PREFSTRENGTH	http://terminology.hl7.org/CodeSystem/v3-ActCode	preference strength	An observation about how important a preference is to the target of the preference.
ADVERSE_REACTION	http://terminology.hl7.org/CodeSystem/v3-ActCode	Adverse Reaction	Indicates that the observation is of an unexpected negative occurrence in the subject suspected to result from the subject's exposure to one or more agents. Observation values would be the symptom resulting from the reaction.
ASSERTION	http://terminology.hl7.org/CodeSystem/v3-ActCode	Assertion	Description:Refines classCode OBS to indicate an observation in which observation.value contains a finding or other nominalized statement, where the encoded information in Observation.value is not altered by Observation.code. For instance, observation.code="ASSERTION" and observation.value="fracture of femur present" is an assertion of a clinical finding of femur fracture.
CASESER	http://terminology.hl7.org/CodeSystem/v3-ActCode	case seriousness criteria	Definition:An observation that provides a characterization of the level of harm to an investigation subject as a result of a reaction or event.
CDIO	http://terminology.hl7.org/CodeSystem/v3-ActCode	case disease imported observation	An observation that states whether the disease was likely acquired outside the jurisdiction of observation, and if so, the nature of the inter-jurisdictional relationship. OpenIssue: This code could be moved to LOINC if it can be done before there are significant implemenations using it.
CRIT	http://terminology.hl7.org/CodeSystem/v3-ActCode	criticality	A clinical judgment as to the worst case result of a future exposure (including substance administration). When the worst case result is assessed to have a life-threatening or organ system threatening potential, it is considered to be of high criticality.
CTMO	http://terminology.hl7.org/CodeSystem/v3-ActCode	case transmission mode observation	An observation that states the mechanism by which disease was acquired by the living subject involved in the public health case. OpenIssue: This code could be moved to LOINC if it can be done before there are significant implemenations using it.
DX	http://terminology.hl7.org/CodeSystem/v3-ActCode	ObservationDiagnosisTypes	Includes all codes defining types of indications such as diagnosis, symptom and other indications such as contrast agents for lab tests.
ADMDX	http://terminology.hl7.org/CodeSystem/v3-ActCode	admitting diagnosis	Admitting diagnosis are the diagnoses documented for administrative purposes as the basis for a hospital admission.
DISDX	http://terminology.hl7.org/CodeSystem/v3-ActCode	discharge diagnosis	Discharge diagnosis are the diagnoses documented for administrative purposes as the time of hospital discharge.
INTDX	http://terminology.hl7.org/CodeSystem/v3-ActCode	intermediate diagnosis	Intermediate diagnoses are those diagnoses documented for administrative purposes during the course of a hospital stay.
NOI	http://terminology.hl7.org/CodeSystem/v3-ActCode	nature of injury	The type of injury that the injury coding specifies.
GISTIER	http://terminology.hl7.org/CodeSystem/v3-ActCode	GIS tier	Description: Accuracy determined as per the GIS tier code system.
HHOBS	http://terminology.hl7.org/CodeSystem/v3-ActCode	household situation observation	Indicates that the observation is of a person’s living situation in a household including the household composition and circumstances.
ISSUE	http://terminology.hl7.org/CodeSystem/v3-ActCode	detected issue	There is a clinical issue for the therapy that makes continuation of the therapy inappropriate. Open Issue: The definition of this code does not correctly represent the concept space of its specializations (children)
_ActAdministrativeDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActAdministrativeDetectedIssueCode	Identifies types of detectyed issues for Act class "ALRT" for the administrative and patient administrative acts domains.
_ActAdministrativeAuthorizationDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActAdministrativeAuthorizationDetectedIssueCode	ActAdministrativeAuthorizationDetectedIssueCode
NAT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Insufficient authorization	The requesting party has insufficient authorization to invoke the interaction.
SUPPRESSED	http://terminology.hl7.org/CodeSystem/v3-ActCode	record suppressed	Description: One or more records in the query response have been suppressed due to consent or privacy restrictions.
VALIDAT	http://terminology.hl7.org/CodeSystem/v3-ActCode	validation issue	Description:The specified element did not pass business-rule validation.
KEY204	http://terminology.hl7.org/CodeSystem/v3-ActCode	Unknown key identifier	The ID of the patient, order, etc., was not found. Used for transactions other than additions, e.g. transfer of a non-existent patient.
KEY205	http://terminology.hl7.org/CodeSystem/v3-ActCode	Duplicate key identifier	The ID of the patient, order, etc., already exists. Used in response to addition transactions (Admit, New Order, etc.).
COMPLY	http://terminology.hl7.org/CodeSystem/v3-ActCode	Compliance Alert	There may be an issue with the patient complying with the intentions of the proposed therapy
DUPTHPY	http://terminology.hl7.org/CodeSystem/v3-ActCode	Duplicate Therapy Alert	The proposed therapy appears to duplicate an existing therapy
DUPTHPCLS	http://terminology.hl7.org/CodeSystem/v3-ActCode	duplicate therapeutic alass alert	Description:The proposed therapy appears to have the same intended therapeutic benefit as an existing therapy, though the specific mechanisms of action vary.
DUPTHPGEN	http://terminology.hl7.org/CodeSystem/v3-ActCode	duplicate generic alert	Description:The proposed therapy appears to have the same intended therapeutic benefit as an existing therapy and uses the same mechanisms of action as the existing therapy.
ABUSE	http://terminology.hl7.org/CodeSystem/v3-ActCode	commonly abused/misused alert	Description:The proposed therapy is frequently misused or abused and therefore should be used with caution and/or monitoring.
FRAUD	http://terminology.hl7.org/CodeSystem/v3-ActCode	potential fraud	Description:The request is suspected to have a fraudulent basis.
PLYDOC	http://terminology.hl7.org/CodeSystem/v3-ActCode	Poly-orderer Alert	A similar or identical therapy was recently ordered by a different practitioner.
PLYPHRM	http://terminology.hl7.org/CodeSystem/v3-ActCode	Poly-supplier Alert	This patient was recently supplied a similar or identical therapy from a different pharmacy or supplier.
DOSE	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dosage problem	Proposed dosage instructions for therapy differ from standard practice.
DOSECOND	http://terminology.hl7.org/CodeSystem/v3-ActCode	dosage-condition alert	Description:Proposed dosage is inappropriate due to patient's medical condition.
DOSEDUR	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dose-Duration Alert	Proposed length of therapy differs from standard practice.
DOSEDURH	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dose-Duration High Alert	Proposed length of therapy is longer than standard practice
DOSEDURHIND	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dose-Duration High for Indication Alert	Proposed length of therapy is longer than standard practice for the identified indication or diagnosis
DOSEDURL	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dose-Duration Low Alert	Proposed length of therapy is shorter than that necessary for therapeutic effect
DOSEDURLIND	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dose-Duration Low for Indication Alert	Proposed length of therapy is shorter than standard practice for the identified indication or diagnosis
DOSEH	http://terminology.hl7.org/CodeSystem/v3-ActCode	High Dose Alert	Proposed dosage exceeds standard practice
DOSEHINDA	http://terminology.hl7.org/CodeSystem/v3-ActCode	High Dose for Age Alert	Proposed dosage exceeds standard practice for the patient's age
DOSEHIND	http://terminology.hl7.org/CodeSystem/v3-ActCode	High Dose for Indication Alert	High Dose for Indication Alert
DOSEHINDSA	http://terminology.hl7.org/CodeSystem/v3-ActCode	High Dose for Height/Surface Area Alert	Proposed dosage exceeds standard practice for the patient's height or body surface area
DOSEHINDW	http://terminology.hl7.org/CodeSystem/v3-ActCode	High Dose for Weight Alert	Proposed dosage exceeds standard practice for the patient's weight
DOSEIVL	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dose-Interval Alert	Proposed dosage interval/timing differs from standard practice
DOSEIVLIND	http://terminology.hl7.org/CodeSystem/v3-ActCode	Dose-Interval for Indication Alert	Proposed dosage interval/timing differs from standard practice for the identified indication or diagnosis
DOSEL	http://terminology.hl7.org/CodeSystem/v3-ActCode	Low Dose Alert	Proposed dosage is below suggested therapeutic levels
DOSELINDA	http://terminology.hl7.org/CodeSystem/v3-ActCode	Low Dose for Age Alert	Proposed dosage is below suggested therapeutic levels for the patient's age
DOSELIND	http://terminology.hl7.org/CodeSystem/v3-ActCode	Low Dose for Indication Alert	Low Dose for Indication Alert
DOSELINDSA	http://terminology.hl7.org/CodeSystem/v3-ActCode	Low Dose for Height/Surface Area Alert	Proposed dosage is below suggested therapeutic levels for the patient's height or body surface area
DOSELINDW	http://terminology.hl7.org/CodeSystem/v3-ActCode	Low Dose for Weight Alert	Proposed dosage is below suggested therapeutic levels for the patient's weight
MDOSE	http://terminology.hl7.org/CodeSystem/v3-ActCode	maximum dosage reached	Description:The maximum quantity of this drug allowed to be administered within a particular time-range (month, year, lifetime) has been reached or exceeded.
OBSA	http://terminology.hl7.org/CodeSystem/v3-ActCode	Observation Alert	Proposed therapy may be inappropriate or contraindicated due to conditions or characteristics of the patient
AGE	http://terminology.hl7.org/CodeSystem/v3-ActCode	Age Alert	Proposed therapy may be inappropriate or contraindicated due to patient age
ADALRT	http://terminology.hl7.org/CodeSystem/v3-ActCode	adult alert	Proposed therapy is outside of the standard practice for an adult patient.
GEALRT	http://terminology.hl7.org/CodeSystem/v3-ActCode	geriatric alert	Proposed therapy is outside of standard practice for a geriatric patient.
PEALRT	http://terminology.hl7.org/CodeSystem/v3-ActCode	pediatric alert	Proposed therapy is outside of the standard practice for a pediatric patient.
COND	http://terminology.hl7.org/CodeSystem/v3-ActCode	Condition Alert	Proposed therapy may be inappropriate or contraindicated due to an existing/recent patient condition or diagnosis
HGHT	http://terminology.hl7.org/CodeSystem/v3-ActCode
LACT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Lactation Alert	Proposed therapy may be inappropriate or contraindicated when breast-feeding
PREG	http://terminology.hl7.org/CodeSystem/v3-ActCode	Pregnancy Alert	Proposed therapy may be inappropriate or contraindicated during pregnancy
WGHT	http://terminology.hl7.org/CodeSystem/v3-ActCode
CREACT	http://terminology.hl7.org/CodeSystem/v3-ActCode	common reaction alert	Description:Proposed therapy may be inappropriate or contraindicated because of a common but non-patient specific reaction to the product. Example:There is no record of a specific sensitivity for the patient, but the presence of the sensitivity is common and therefore caution is warranted.
GEN	http://terminology.hl7.org/CodeSystem/v3-ActCode	Genetic Alert	Proposed therapy may be inappropriate or contraindicated due to patient genetic indicators.
GEND	http://terminology.hl7.org/CodeSystem/v3-ActCode	Gender Alert	Proposed therapy may be inappropriate or contraindicated due to patient gender.
LAB	http://terminology.hl7.org/CodeSystem/v3-ActCode	Lab Alert	Proposed therapy may be inappropriate or contraindicated due to recent lab test results
REACT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Reaction Alert	Proposed therapy may be inappropriate or contraindicated based on the potential for a patient reaction to the proposed product
ALGY	http://terminology.hl7.org/CodeSystem/v3-ActCode	Allergy Alert	Proposed therapy may be inappropriate or contraindicated because of a recorded patient allergy to the proposed product. (Allergies are immune based reactions.)
INT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Intolerance Alert	Proposed therapy may be inappropriate or contraindicated because of a recorded patient intolerance to the proposed product. (Intolerances are non-immune based sensitivities.)
RREACT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Related Reaction Alert	Proposed therapy may be inappropriate or contraindicated because of a potential patient reaction to a cross-sensitivity related product.
RALG	http://terminology.hl7.org/CodeSystem/v3-ActCode	Related Allergy Alert	Proposed therapy may be inappropriate or contraindicated because of a recorded patient allergy to a cross-sensitivity related product. (Allergies are immune based reactions.)
RAR	http://terminology.hl7.org/CodeSystem/v3-ActCode	Related Prior Reaction Alert	Proposed therapy may be inappropriate or contraindicated because of a recorded prior adverse reaction to a cross-sensitivity related product.
RINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Related Intolerance Alert	Proposed therapy may be inappropriate or contraindicated because of a recorded patient intolerance to a cross-sensitivity related product. (Intolerances are non-immune based sensitivities.)
BUS	http://terminology.hl7.org/CodeSystem/v3-ActCode	business constraint violation	Description:A local business rule relating multiple elements has been violated.
CODE_INVAL	http://terminology.hl7.org/CodeSystem/v3-ActCode	code is not valid	Description:The specified code is not valid against the list of codes allowed for the element.
CODE_DEPREC	http://terminology.hl7.org/CodeSystem/v3-ActCode	code has been deprecated	Description:The specified code has been deprecated and should no longer be used. Select another code from the code system.
FORMAT	http://terminology.hl7.org/CodeSystem/v3-ActCode	invalid format	Description:The element does not follow the formatting or type rules defined for the field.
ILLEGAL	http://terminology.hl7.org/CodeSystem/v3-ActCode	illegal	Description:The request is missing elements or contains elements which cause it to not meet the legal standards for actioning.
LEN_RANGE	http://terminology.hl7.org/CodeSystem/v3-ActCode	length out of range	Description:The length of the data specified falls out of the range defined for the element.
LEN_LONG	http://terminology.hl7.org/CodeSystem/v3-ActCode	length is too long	Description:The length of the data specified is greater than the maximum length defined for the element.
LEN_SHORT	http://terminology.hl7.org/CodeSystem/v3-ActCode	length is too short	Description:The length of the data specified is less than the minimum length defined for the element.
MISSCOND	http://terminology.hl7.org/CodeSystem/v3-ActCode	conditional element missing	Description:The specified element must be specified with a non-null value under certain conditions. In this case, the conditions are true but the element is still missing or null.
MISSMAND	http://terminology.hl7.org/CodeSystem/v3-ActCode	mandatory element missing	Description:The specified element is mandatory and was not included in the instance.
NODUPS	http://terminology.hl7.org/CodeSystem/v3-ActCode	duplicate values are not permitted	Description:More than one element with the same value exists in the set. Duplicates not permission in this set in a set.
NOPERSIST	http://terminology.hl7.org/CodeSystem/v3-ActCode	element will not be persisted	Description: Element in submitted message will not persist in data storage based on detected issue.
REP_RANGE	http://terminology.hl7.org/CodeSystem/v3-ActCode	repetitions out of range	Description:The number of repeating elements falls outside the range of the allowed number of repetitions.
MAXOCCURS	http://terminology.hl7.org/CodeSystem/v3-ActCode	repetitions above maximum	Description:The number of repeating elements is above the maximum number of repetitions allowed.
MINOCCURS	http://terminology.hl7.org/CodeSystem/v3-ActCode	repetitions below minimum	Description:The number of repeating elements is below the minimum number of repetitions allowed.
_ActAdministrativeRuleDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActAdministrativeRuleDetectedIssueCode	ActAdministrativeRuleDetectedIssueCode
KEY206	http://terminology.hl7.org/CodeSystem/v3-ActCode	non-matching identification	Description: Metadata associated with the identification (e.g. name or gender) does not match the identification being verified.
OBSOLETE	http://terminology.hl7.org/CodeSystem/v3-ActCode	obsolete record returned	Description: One or more records in the query response have a status of 'obsolete'.
_ActSuppliedItemDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	ActSuppliedItemDetectedIssueCode	Identifies types of detected issues regarding the administration or supply of an item to a patient.
_AdministrationDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	AdministrationDetectedIssueCode	Administration of the proposed therapy may be inappropriate or contraindicated as proposed
_AppropriatenessDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	AppropriatenessDetectedIssueCode	AppropriatenessDetectedIssueCode
_InteractionDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	InteractionDetectedIssueCode	InteractionDetectedIssueCode
FOOD	http://terminology.hl7.org/CodeSystem/v3-ActCode	Food Interaction Alert	Proposed therapy may interact with certain foods
TPROD	http://terminology.hl7.org/CodeSystem/v3-ActCode	Therapeutic Product Alert	Proposed therapy may interact with an existing or recent therapeutic product
DRG	http://terminology.hl7.org/CodeSystem/v3-ActCode	Drug Interaction Alert	Proposed therapy may interact with an existing or recent drug therapy
NHP	http://terminology.hl7.org/CodeSystem/v3-ActCode	Natural Health Product Alert	Proposed therapy may interact with existing or recent natural health product therapy
NONRX	http://terminology.hl7.org/CodeSystem/v3-ActCode	Non-Prescription Interaction Alert	Proposed therapy may interact with a non-prescription drug (e.g. alcohol, tobacco, Aspirin)
PREVINEF	http://terminology.hl7.org/CodeSystem/v3-ActCode	previously ineffective	Definition:The same or similar treatment has previously been attempted with the patient without achieving a positive effect.
DACT	http://terminology.hl7.org/CodeSystem/v3-ActCode	drug action detected issue	Description:Proposed therapy may be contraindicated or ineffective based on an existing or recent drug therapy.
TIME	http://terminology.hl7.org/CodeSystem/v3-ActCode	timing detected issue	Description:Proposed therapy may be inappropriate or ineffective based on the proposed start or end time.
ALRTENDLATE	http://terminology.hl7.org/CodeSystem/v3-ActCode	end too late alert	Definition:Proposed therapy may be inappropriate or ineffective because the end of administration is too close to another planned therapy.
ALRTSTRTLATE	http://terminology.hl7.org/CodeSystem/v3-ActCode	start too late alert	Definition:Proposed therapy may be inappropriate or ineffective because the start of administration is too late after the onset of the condition.
_TimingDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	TimingDetectedIssueCode	Proposed therapy may be inappropriate or ineffective based on the proposed start or end time.
ENDLATE	http://terminology.hl7.org/CodeSystem/v3-ActCode	End Too Late Alert	Proposed therapy may be inappropriate or ineffective because the end of administration is too close to another planned therapy
STRTLATE	http://terminology.hl7.org/CodeSystem/v3-ActCode	Start Too Late Alert	Proposed therapy may be inappropriate or ineffective because the start of administration is too late after the onset of the condition
_SupplyDetectedIssueCode	http://terminology.hl7.org/CodeSystem/v3-ActCode	SupplyDetectedIssueCode	Supplying the product at this time may be inappropriate or indicate compliance issues with the associated therapy
ALLDONE	http://terminology.hl7.org/CodeSystem/v3-ActCode	already performed	Definition:The requested action has already been performed and so this request has no effect
FULFIL	http://terminology.hl7.org/CodeSystem/v3-ActCode	fulfillment alert	Definition:The therapy being performed is in some way out of alignment with the requested therapy.
NOTACTN	http://terminology.hl7.org/CodeSystem/v3-ActCode	no longer actionable	Definition:The status of the request being fulfilled has changed such that it is no longer actionable. This may be because the request has expired, has already been completely fulfilled or has been otherwise stopped or disabled. (Not used for 'suspended' orders.)
NOTEQUIV	http://terminology.hl7.org/CodeSystem/v3-ActCode	not equivalent alert	Definition:The therapy being performed is not sufficiently equivalent to the therapy which was requested.
NOTEQUIVGEN	http://terminology.hl7.org/CodeSystem/v3-ActCode	not generically equivalent alert	Definition:The therapy being performed is not generically equivalent (having the identical biological action) to the therapy which was requested.
NOTEQUIVTHER	http://terminology.hl7.org/CodeSystem/v3-ActCode	not therapeutically equivalent alert	Definition:The therapy being performed is not therapeutically equivalent (having the same overall patient effect) to the therapy which was requested.
TIMING	http://terminology.hl7.org/CodeSystem/v3-ActCode	event timing incorrect alert	Definition:The therapy is being performed at a time which diverges from the time the therapy was requested
INTERVAL	http://terminology.hl7.org/CodeSystem/v3-ActCode	outside requested time	Definition:The therapy action is being performed outside the bounds of the time period requested
MINFREQ	http://terminology.hl7.org/CodeSystem/v3-ActCode	too soon within frequency based on the usage	Definition:The therapy action is being performed too soon after the previous occurrence based on the requested frequency
HELD	http://terminology.hl7.org/CodeSystem/v3-ActCode	held/suspended alert	Definition:There should be no actions taken in fulfillment of a request that has been held or suspended.
TOOLATE	http://terminology.hl7.org/CodeSystem/v3-ActCode	Refill Too Late Alert	The patient is receiving a subsequent fill significantly later than would be expected based on the amount previously supplied and the therapy dosage instructions
TOOSOON	http://terminology.hl7.org/CodeSystem/v3-ActCode	Refill Too Soon Alert	The patient is receiving a subsequent fill significantly earlier than would be expected based on the amount previously supplied and the therapy dosage instructions
HISTORIC	http://terminology.hl7.org/CodeSystem/v3-ActCode	record recorded as historical	Description: While the record was accepted in the repository, there is a more recent version of a record of this type.
PATPREF	http://terminology.hl7.org/CodeSystem/v3-ActCode	violates stated preferences	Definition:The proposed therapy goes against preferences or consent constraints recorded in the patient's record.
PATPREFALT	http://terminology.hl7.org/CodeSystem/v3-ActCode	violates stated preferences, alternate available	Definition:The proposed therapy goes against preferences or consent constraints recorded in the patient's record. An alternate therapy meeting those constraints is available.
KSUBJ	http://terminology.hl7.org/CodeSystem/v3-ActCode	knowledge subject	Categorization of types of observation that capture the main clinical knowledge subject which may be a medication, a laboratory test, a disease.
KSUBT	http://terminology.hl7.org/CodeSystem/v3-ActCode	knowledge subtopic	Categorization of types of observation that capture a knowledge subtopic which might be treatment, etiology, or prognosis.
OINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	intolerance	Hypersensitivity resulting in an adverse reaction upon exposure to an agent.
ALG	http://terminology.hl7.org/CodeSystem/v3-ActCode	Allergy	Hypersensitivity to an agent caused by an immunologic response to an initial exposure
DALG	http://terminology.hl7.org/CodeSystem/v3-ActCode	Drug Allergy	An allergy to a pharmaceutical product.
EALG	http://terminology.hl7.org/CodeSystem/v3-ActCode	Environmental Allergy	An allergy to a substance other than a drug or a food. E.g. Latex, pollen, etc.
FALG	http://terminology.hl7.org/CodeSystem/v3-ActCode	Food Allergy	An allergy to a substance generally consumed for nutritional purposes.
DINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Drug Intolerance	Hypersensitivity resulting in an adverse reaction upon exposure to a drug.
DNAINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Drug Non-Allergy Intolerance	Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure
EINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Environmental Intolerance	Hypersensitivity resulting in an adverse reaction upon exposure to environmental conditions.
ENAINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Environmental Non-Allergy Intolerance	Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure
FINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Food Intolerance	Hypersensitivity resulting in an adverse reaction upon exposure to food.
FNAINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Food Non-Allergy Intolerance	Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure
NAINT	http://terminology.hl7.org/CodeSystem/v3-ActCode	Non-Allergy Intolerance	Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure
SEV	http://terminology.hl7.org/CodeSystem/v3-ActCode	Severity Observation	A subjective evaluation of the seriousness or intensity associated with another observation.
_FDALabelData	http://terminology.hl7.org/CodeSystem/v3-ActCode	FDALabelData	FDA label data
FDACOATING	http://terminology.hl7.org/CodeSystem/v3-ActCode	coating	FDA label coating
FDACOLOR	http://terminology.hl7.org/CodeSystem/v3-ActCode	color	FDA label color
FDAIMPRINTCD	http://terminology.hl7.org/CodeSystem/v3-ActCode	imprint code	FDA label imprint code
FDALOGO	http://terminology.hl7.org/CodeSystem/v3-ActCode	logo	FDA label logo
FDASCORING	http://terminology.hl7.org/CodeSystem/v3-ActCode	scoring	FDA label scoring
FDASHAPE	http://terminology.hl7.org/CodeSystem/v3-ActCode	shape	FDA label shape
FDASIZE	http://terminology.hl7.org/CodeSystem/v3-ActCode	size	FDA label size
1-8	http://loinc.org	Acyclovir [Susceptibility]
10-9	http://loinc.org	Amdinocillin [Susceptibility] by Serum bactericidal titer
100-8	http://loinc.org	Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
1000-9	http://loinc.org	DBG Ab [Presence] in Serum or Plasma from Blood product unit
10000-8	http://loinc.org	R wave duration in lead AVR
10001-6	http://loinc.org	R wave duration in lead I
10002-4	http://loinc.org	R wave duration in lead II
10003-2	http://loinc.org	R wave duration in lead III
10004-0	http://loinc.org	R wave duration in lead V1
10005-7	http://loinc.org	R wave duration in lead V2
10006-5	http://loinc.org	R wave duration in lead V3
10007-3	http://loinc.org	R wave duration in lead V4
10008-1	http://loinc.org	R wave duration in lead V5
10009-9	http://loinc.org	R wave duration in lead V6
1001-7	http://loinc.org	DBG Ab [Presence] in Serum or Plasma from Donor
10010-7	http://loinc.org	R' wave amplitude in lead AVF
10011-5	http://loinc.org	R' wave amplitude in lead AVL
10012-3	http://loinc.org	R' wave amplitude in lead AVR
10013-1	http://loinc.org	R' wave amplitude in lead I
10014-9	http://loinc.org	R' wave amplitude in lead II
10015-6	http://loinc.org	R' wave amplitude in lead III
10016-4	http://loinc.org	R' wave amplitude in lead V1
10017-2	http://loinc.org	R' wave amplitude in lead V2
10018-0	http://loinc.org	R' wave amplitude in lead V3
10019-8	http://loinc.org	R' wave amplitude in lead V4
1002-5	http://loinc.org	DBG Ab [Presence] in Serum or Plasma
10020-6	http://loinc.org	R' wave amplitude in lead V5
10021-4	http://loinc.org	R' wave amplitude in lead V6
10022-2	http://loinc.org	R' wave duration in lead AVF
10023-0	http://loinc.org	R' wave duration in lead AVL
10024-8	http://loinc.org	R' wave duration in lead AVR
10025-5	http://loinc.org	R' wave duration in lead I
10026-3	http://loinc.org	R' wave duration in lead II
10027-1	http://loinc.org	R' wave duration in lead III
10028-9	http://loinc.org	R' wave duration in lead V1
10029-7	http://loinc.org	R' wave duration in lead V2
1003-3	http://loinc.org	Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma
10030-5	http://loinc.org	R' wave duration in lead V3
10031-3	http://loinc.org	R' wave duration in lead V4
10032-1	http://loinc.org	R' wave duration in lead V5
10033-9	http://loinc.org	R' wave duration in lead V6
10034-7	http://loinc.org	S wave amplitude in lead AVF
10035-4	http://loinc.org	S wave amplitude in lead AVL
10036-2	http://loinc.org	S wave amplitude in lead AVR
10037-0	http://loinc.org	S wave amplitude in lead I
10038-8	http://loinc.org	S wave amplitude in lead II
10039-6	http://loinc.org	S wave amplitude in lead III
1004-1	http://loinc.org	Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells
10040-4	http://loinc.org	S wave amplitude in lead V1
10041-2	http://loinc.org	S wave amplitude in lead V2
10042-0	http://loinc.org	S wave amplitude in lead V3
10043-8	http://loinc.org	S wave amplitude in lead V4
10044-6	http://loinc.org	S wave amplitude in lead V5
10045-3	http://loinc.org	S wave amplitude in lead V6
10046-1	http://loinc.org	S wave duration in lead AVF
10047-9	http://loinc.org	S wave duration in lead AVL
10048-7	http://loinc.org	S wave duration in lead AVR
10049-5	http://loinc.org	S wave duration in lead I
1005-8	http://loinc.org	Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma
10050-3	http://loinc.org	S wave duration in lead II
10051-1	http://loinc.org	S wave duration in lead III
10052-9	http://loinc.org	S wave duration in lead V1
10053-7	http://loinc.org	S wave duration in lead V2
10054-5	http://loinc.org	S wave duration in lead V3
10055-2	http://loinc.org	S wave duration in lead V4
10056-0	http://loinc.org	S wave duration in lead V5
10057-8	http://loinc.org	S wave duration in lead V6
10058-6	http://loinc.org	S' wave amplitude in lead AVF
10059-4	http://loinc.org	S' wave amplitude in lead AVL
1006-6	http://loinc.org	Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells
10060-2	http://loinc.org	S' wave amplitude in lead AVR
10061-0	http://loinc.org	S' wave amplitude in lead I
10062-8	http://loinc.org	S' wave amplitude in lead II
10063-6	http://loinc.org	S' wave amplitude in lead III
10064-4	http://loinc.org	S' wave amplitude in lead V1
10065-1	http://loinc.org	S' wave amplitude in lead V2
10066-9	http://loinc.org	S' wave amplitude in lead V3
10067-7	http://loinc.org	S' wave amplitude in lead V4
10068-5	http://loinc.org	S' wave amplitude in lead V5
10069-3	http://loinc.org	S' wave amplitude in lead V6
1007-4	http://loinc.org	Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells
10070-1	http://loinc.org	S' wave duration in lead AVF
10071-9	http://loinc.org	S' wave duration in lead AVL
10072-7	http://loinc.org	S' wave duration in lead AVR
10073-5	http://loinc.org	S' wave duration in lead I
10074-3	http://loinc.org	S' wave duration in lead II
10075-0	http://loinc.org	S' wave duration in lead III
10076-8	http://loinc.org	S' wave duration in lead V1
10077-6	http://loinc.org	S' wave duration in lead V2
10078-4	http://loinc.org	S' wave duration in lead V3
10079-2	http://loinc.org	S' wave duration in lead V4
1008-2	http://loinc.org	Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma
10080-0	http://loinc.org	S' wave duration in lead V5
10081-8	http://loinc.org	S' wave duration in lead V6
10082-6	http://loinc.org	ST initial amplitude 6 ms in lead AVF
10083-4	http://loinc.org	ST initial amplitude 6 ms in lead AVL
10084-2	http://loinc.org	ST initial amplitude 6 ms in lead AVR
10085-9	http://loinc.org	ST initial amplitude 6 ms in lead I
10086-7	http://loinc.org	ST initial amplitude 6 ms in lead II
10087-5	http://loinc.org	ST initial amplitude 6 ms in lead III
10088-3	http://loinc.org	ST initial amplitude 6 ms in lead V1
10089-1	http://loinc.org	ST initial amplitude 6 ms in lead V2
1009-0	http://loinc.org	Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells
10090-9	http://loinc.org	ST initial amplitude 6 ms in lead V3
10091-7	http://loinc.org	ST initial amplitude 6 ms in lead V4
10092-5	http://loinc.org	ST initial amplitude 6 ms in lead V5
10093-3	http://loinc.org	ST initial amplitude 6 ms in lead V6
10094-1	http://loinc.org	ST slope in lead AVF
10095-8	http://loinc.org	ST slope in lead AVL
10096-6	http://loinc.org	ST slope in lead AVR
10097-4	http://loinc.org	ST slope in lead I
10098-2	http://loinc.org	ST slope in lead II
10099-0	http://loinc.org	ST slope in lead III
101-6	http://loinc.org	Cefoperazone [Susceptibility] by Disk diffusion (KB)
1010-8	http://loinc.org	E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit
10100-6	http://loinc.org	ST slope in lead V1
10101-4	http://loinc.org	ST slope in lead V2
10102-2	http://loinc.org	ST slope in lead V3
10103-0	http://loinc.org	ST slope in lead V4
10104-8	http://loinc.org	ST slope in lead V5
10105-5	http://loinc.org	ST slope in lead V6
10106-3	http://loinc.org	ST wave end displacement in lead AVF
10107-1	http://loinc.org	ST wave end displacement in lead AVL
10108-9	http://loinc.org	ST wave end displacement in lead AVR
10109-7	http://loinc.org	ST wave end displacement in lead I
1011-6	http://loinc.org	E sup(w) Ab [Presence] in Serum or Plasma from Donor
10110-5	http://loinc.org	ST wave end displacement in lead II
10111-3	http://loinc.org	ST wave end displacement in lead III
10112-1	http://loinc.org	ST wave end displacement in lead V1
10113-9	http://loinc.org	ST wave end displacement in lead V2
10114-7	http://loinc.org	ST wave end displacement in lead V3
10115-4	http://loinc.org	ST wave end displacement in lead V4
10116-2	http://loinc.org	ST wave end displacement in lead V5
10117-0	http://loinc.org	ST wave end displacement in lead V6
10118-8	http://loinc.org	ST wave mid displacement in lead AVF
10119-6	http://loinc.org	ST wave mid displacement in lead AVL
1012-4	http://loinc.org	E sup(w) Ab [Presence] in Serum or Plasma
10120-4	http://loinc.org	ST wave mid displacement in lead AVR
10121-2	http://loinc.org	ST wave mid displacement in lead I
10122-0	http://loinc.org	ST wave mid displacement in lead II
10123-8	http://loinc.org	ST wave mid displacement in lead III
10124-6	http://loinc.org	ST wave mid displacement in lead V1
10125-3	http://loinc.org	ST wave mid displacement in lead V2
10126-1	http://loinc.org	ST wave mid displacement in lead V3
10127-9	http://loinc.org	ST wave mid displacement in lead V4
10128-7	http://loinc.org	ST wave mid displacement in lead V5
10129-5	http://loinc.org	ST wave mid displacement in lead V6
1013-2	http://loinc.org	E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit
10130-3	http://loinc.org	T' wave amplitude in lead AVF
10131-1	http://loinc.org	T' wave amplitude in lead AVL
10132-9	http://loinc.org	T' wave amplitude in lead AVR
10133-7	http://loinc.org	T' wave amplitude in lead I
10134-5	http://loinc.org	T' wave amplitude in lead II
10135-2	http://loinc.org	T' wave amplitude in lead III
10136-0	http://loinc.org	T' wave amplitude in lead V1
10137-8	http://loinc.org	T' wave amplitude in lead V2
10138-6	http://loinc.org	T' wave amplitude in lead V3
10139-4	http://loinc.org	T' wave amplitude in lead V4
1014-0	http://loinc.org	E sup(w) Ag [Presence] on Red Blood Cells from Donor
10140-2	http://loinc.org	T' wave amplitude in lead V5
10141-0	http://loinc.org	T' wave amplitude in lead V6
10142-8	http://loinc.org	T wave amplitude in lead AVF
10143-6	http://loinc.org	T wave amplitude in lead AVL
10144-4	http://loinc.org	T wave amplitude in lead AVR
10145-1	http://loinc.org	T wave amplitude in lead I
10146-9	http://loinc.org	T wave amplitude in lead II
10147-7	http://loinc.org	T wave amplitude in lead III
10148-5	http://loinc.org	T wave amplitude in lead V1
10149-3	http://loinc.org	T wave amplitude in lead V2
1015-7	http://loinc.org	E sup(w) Ag [Presence] on Red Blood Cells
10150-1	http://loinc.org	T wave amplitude in lead V3
10151-9	http://loinc.org	T wave amplitude in lead V4
10152-7	http://loinc.org	T wave amplitude in lead V5
10153-5	http://loinc.org	T wave amplitude in lead V6
10154-3	http://loinc.org	Chief complaint Narrative - Reported
10155-0	http://loinc.org	History of allergies, reported
10156-8	http://loinc.org	History of Childhood diseases Narrative
10157-6	http://loinc.org	History of family member diseases Narrative
10158-4	http://loinc.org	History of Functional status Narrative
10159-2	http://loinc.org	History of Industrial exposure Narrative
1016-5	http://loinc.org	E Ab [Presence] in Serum or Plasma from Blood product unit
10160-0	http://loinc.org	History of Medication use Narrative
10161-8	http://loinc.org	History of Occupational exposure Narrative
10162-6	http://loinc.org	History of pregnancies Narrative
10163-4	http://loinc.org	History of pregnancies
10164-2	http://loinc.org	History of Present illness Narrative
10165-9	http://loinc.org	Deprecated History of psychiatric symptoms and diseases Narrative
10166-7	http://loinc.org	History of Social function Narrative
10167-5	http://loinc.org	History of Surgical procedures Narrative
10168-3	http://loinc.org	History of Cardiovascular system disorders Narrative
10169-1	http://loinc.org	History of Ear disorders Narrative
1017-3	http://loinc.org	E Ab [Presence] in Serum or Plasma from Donor
10170-9	http://loinc.org	History of Endocrine system disorders Narrative
10171-7	http://loinc.org	History of Eyes disorders Narrative
10172-5	http://loinc.org	History of Hematologic system disorders Narrative
10173-3	http://loinc.org	History of Musculoskeletal system disorders Narrative
10174-1	http://loinc.org	History of Nose disorders Narrative
10175-8	http://loinc.org	History of Oral cavity disorders Narrative
10176-6	http://loinc.org	History of Reproductive system disorders Narrative
10177-4	http://loinc.org	History of Respiratory system disorders Narrative
10178-2	http://loinc.org	History of Skin disorders Narrative
10179-0	http://loinc.org	History of Throat and Neck disorders Narrative
1018-1	http://loinc.org	E Ab [Presence] in Serum or Plasma
10180-8	http://loinc.org	History of Throat and Neck disorders
10181-6	http://loinc.org	History of Urinary tract disorders Narrative
10182-4	http://loinc.org	History of Travel Narrative
10183-2	http://loinc.org	Hospital discharge medications Narrative
10184-0	http://loinc.org	Hospital discharge physical findings Narrative
10185-7	http://loinc.org	Hospital discharge procedures Narrative
10186-5	http://loinc.org	Identifying information Narrative Observed
10187-3	http://loinc.org	Review of systems Narrative - Reported
10188-1	http://loinc.org	Review of systems overview Narrative - Reported
10189-9	http://loinc.org	Review of systems overview - Reported
1019-9	http://loinc.org	E Ag [Presence] on Red Blood Cells from Blood product unit
10190-7	http://loinc.org	Mental status Narrative
10191-5	http://loinc.org	Physical findings of Abdomen Narrative
10192-3	http://loinc.org	Physical findings of Back Narrative
10193-1	http://loinc.org	Physical findings of Breasts Narrative
10194-9	http://loinc.org	Physical findings of Neurologic deep tendon reflexes Narrative
10195-6	http://loinc.org	Physical findings of Ear Narrative
10196-4	http://loinc.org	Physical findings of Extremities Narrative
10197-2	http://loinc.org	Physical findings of Eye Narrative
10198-0	http://loinc.org	Physical findings of Genitourinary tract Narrative
10199-8	http://loinc.org	Physical findings of Head Narrative
102-4	http://loinc.org	Cefoperazone [Susceptibility] by Serum bactericidal titer
1020-7	http://loinc.org	E Ag [Presence] on Red Blood Cells from Donor
10200-4	http://loinc.org	Physical findings of Heart Narrative
10201-2	http://loinc.org	Physical findings of Mouth and Throat and Teeth Narrative
10202-0	http://loinc.org	Physical findings of Nervous system Narrative
10203-8	http://loinc.org	Physical findings of Nose Narrative
10204-6	http://loinc.org	Physical findings of Pelvis Narrative
10205-3	http://loinc.org	Physical findings of Rectum Narrative
10206-1	http://loinc.org	Physical findings of Skin Narrative
10207-9	http://loinc.org	Physical findings of Thorax and Lungs Narrative
10208-7	http://loinc.org	Physical findings of Vessels Narrative
10209-5	http://loinc.org	Physical findings of Neurologic balance and Coordination Narrative
1021-5	http://loinc.org	E Ag [Presence] on Red Blood Cells
10210-3	http://loinc.org	Physical findings of General status Narrative
10211-1	http://loinc.org	Physical findings of Sense of touch Narrative
10212-9	http://loinc.org	Physical findings of Strength Narrative
10213-7	http://loinc.org	Surgical operation note anesthesia Narrative
10214-5	http://loinc.org	Surgical operation note anesthesia duration
10215-2	http://loinc.org	Surgical operation note findings Narrative
10216-0	http://loinc.org	Surgical operation note fluids Narrative
10217-8	http://loinc.org	Surgical operation note indications [Interpretation] Narrative
10218-6	http://loinc.org	Surgical operation note postoperative diagnosis Narrative
10219-4	http://loinc.org	Surgical operation note preoperative diagnosis Narrative
1022-3	http://loinc.org	Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
10220-2	http://loinc.org	Surgical operation note prep time duration
10221-0	http://loinc.org	Surgical operation note specimens taken Narrative
10222-8	http://loinc.org	Surgical operation note surgical complications [Interpretation] Narrative
10223-6	http://loinc.org	Surgical operation note surgical procedure Narrative
10224-4	http://loinc.org	Hemodynamic method special circumstances
10225-1	http://loinc.org	Cardiac measurement device Institution inventory number
10226-9	http://loinc.org	Oxygen content in Intravascular space
10227-7	http://loinc.org	Cardiac measurement device Vendor model number
10228-5	http://loinc.org	Cardiac measurement device Vendor serial number
10229-3	http://loinc.org	Hemodynamic method Type of
1023-1	http://loinc.org	Fy sup(a) Ab [Presence] in Serum or Plasma from Donor
10230-1	http://loinc.org	Left ventricular Ejection fraction
10231-9	http://loinc.org	Right ventricular Ejection fraction
10232-7	http://loinc.org	Oxygen content in Aorta root
10233-5	http://loinc.org	Oxygen content in Left atrium
10234-3	http://loinc.org	Oxygen content in Right atrium
10235-0	http://loinc.org	Oxygen content in High right atrium
10236-8	http://loinc.org	Oxygen content in Low right atrium
10237-6	http://loinc.org	Oxygen content in Mid right atrium
10238-4	http://loinc.org	Oxygen content in Left ventricle
10239-2	http://loinc.org	Oxygen content in Right ventricular outflow tract
1024-9	http://loinc.org	Fy sup(a) Ab [Presence] in Serum or Plasma
10240-0	http://loinc.org	Oxygen content in Right ventricle
10241-8	http://loinc.org	Oxygen content in Coronary sinus
10242-6	http://loinc.org	Oxygen content in Ductus arteriosus
10243-4	http://loinc.org	Oxygen content in Inferior vena cava
10244-2	http://loinc.org	Oxygen content in Left pulmonary artery
10245-9	http://loinc.org	Oxygen content in Main pulmonary artery
10246-7	http://loinc.org	Oxygen content in Right pulmonary artery
10247-5	http://loinc.org	Oxygen content in Pulmonary wedge
10248-3	http://loinc.org	Oxygen content in Superior vena cava
10249-1	http://loinc.org	Heart rate device Institution inventory number
1025-6	http://loinc.org	Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
10250-9	http://loinc.org	Heart rate device Vendor model number
10251-7	http://loinc.org	Heart rate device Vendor serial number
10252-5	http://loinc.org	Biliary drain site
10253-3	http://loinc.org	Type of Biliary drain
10254-1	http://loinc.org	Type of Peritoneal drain
10255-8	http://loinc.org	Type of Subarachnoid drain
10256-6	http://loinc.org	Biliary drain Institution inventory number
10257-4	http://loinc.org	Chest tube Institution inventory number
10258-2	http://loinc.org	Enteral tube Institution inventory number
10259-0	http://loinc.org	Gastrostomy tube Institution inventory number
1026-4	http://loinc.org	Fy sup(a) Ag [Presence] on Red Blood Cells from Donor
10260-8	http://loinc.org	GI tube Institution inventory number
10261-6	http://loinc.org	Intravascular tube Institution inventory number
10262-4	http://loinc.org	IO tube Institution inventory number
10263-2	http://loinc.org	Nasogastric tube Institution inventory number
10264-0	http://loinc.org	Oral tube Institution inventory number
10265-7	http://loinc.org	Peritoneal drain Institution inventory number
10266-5	http://loinc.org	Peritoneal tube Institution inventory number
10267-3	http://loinc.org	Rate control device Institution inventory number
10268-1	http://loinc.org	Stool collection device Institution inventory number
10269-9	http://loinc.org	Subarachnoid drain Institution inventory number
1027-2	http://loinc.org	Fy sup(a) Ag [Presence] on Red Blood Cells
10270-7	http://loinc.org	Synovial drain Institution inventory number
10271-5	http://loinc.org	Tube or drain Institution inventory number
10272-3	http://loinc.org	Upper GI tube Institution inventory number
10273-1	http://loinc.org	Bladder irrigation tube Institution inventory number
10274-9	http://loinc.org	Urine tube Institution inventory number
10275-6	http://loinc.org	Wound drain device Institution inventory number
10276-4	http://loinc.org	Peritoneal drain site
10277-2	http://loinc.org	Stool collection site
10278-0	http://loinc.org	Subarachnoid drain site
10279-8	http://loinc.org	Biliary drain Vendor model number
1028-0	http://loinc.org	Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
10280-6	http://loinc.org	Chest tube Vendor model number
10281-4	http://loinc.org	Enteral tube Vendor model number
10282-2	http://loinc.org	Gastrostomy tube Vendor model number
10283-0	http://loinc.org	GI tube Vendor model number
10284-8	http://loinc.org	Intravascular tube Vendor model number
10285-5	http://loinc.org	IO tube Vendor model number
10286-3	http://loinc.org	Nasogastric tube Vendor model number
10287-1	http://loinc.org	Oral tube Vendor model number
10288-9	http://loinc.org	Peritoneal drain Vendor model number
10289-7	http://loinc.org	Peritoneal tube Vendor model number
1029-8	http://loinc.org	Fy sup(b) Ab [Presence] in Serum or Plasma from Donor
10290-5	http://loinc.org	Rate control device Vendor model number
10291-3	http://loinc.org	Stool collection device Vendor model number
10292-1	http://loinc.org	Subarachnoid drain Vendor model number
10293-9	http://loinc.org	Synovial drain Vendor model number
10294-7	http://loinc.org	Tube or drain Vendor model number
10295-4	http://loinc.org	Upper GI tube Vendor model number
10296-2	http://loinc.org	Bladder irrigation tube Vendor model number
10297-0	http://loinc.org	Urine tube Vendor model number
10298-8	http://loinc.org	Wound drain device Vendor model number
10299-6	http://loinc.org	Biliary drain Vendor serial number
103-2	http://loinc.org	Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)
1030-6	http://loinc.org	Fy sup(b) Ab [Presence] in Serum or Plasma
10300-2	http://loinc.org	Chest tube Vendor serial number
10301-0	http://loinc.org	Enteral tube Vendor serial number
10302-8	http://loinc.org	Gastrostomy tube Vendor serial number
10303-6	http://loinc.org	GI tube Vendor serial number
10304-4	http://loinc.org	Intravascular tube Vendor serial number
10305-1	http://loinc.org	IO tube Vendor serial number
10306-9	http://loinc.org	Nasogastric tube Vendor serial number
10307-7	http://loinc.org	Oral tube Vendor serial number
10308-5	http://loinc.org	Peritoneal drain Vendor serial number
10309-3	http://loinc.org	Peritoneal tube Vendor serial number
1031-4	http://loinc.org	Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
10310-1	http://loinc.org	Rate control device Vendor serial number
10311-9	http://loinc.org	Stool collection device Vendor serial number
10312-7	http://loinc.org	Subarachnoid drain Vendor serial number
10313-5	http://loinc.org	Synovial drain Vendor serial number
10314-3	http://loinc.org	Tube or drain Vendor serial number
10315-0	http://loinc.org	Upper GI tube Vendor serial number
10316-8	http://loinc.org	Bladder irrigation tube Vendor serial number
10317-6	http://loinc.org	Urine tube Vendor serial number
10318-4	http://loinc.org	Wound drain device Vendor serial number
10319-2	http://loinc.org	Enema device Institution inventory number
1032-2	http://loinc.org	Fy sup(b) Ag [Presence] on Red Blood Cells from Donor
10320-0	http://loinc.org	Enema device Vendor model number
10321-8	http://loinc.org	Enema device Vendor serial number
10322-6	http://loinc.org	Potassium intake 24 hour
10323-4	http://loinc.org	Wound drain fluid [Appearance] Lower GI tract
10324-2	http://loinc.org	Breath rate device Institution inventory number
10325-9	http://loinc.org	Breath rate device Vendor model number
10326-7	http://loinc.org	Breath rate device Vendor serial number
10327-5	http://loinc.org	Eosinophils/100 leukocytes in Sputum by Manual count
10328-3	http://loinc.org	Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count
10329-1	http://loinc.org	Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count
1033-0	http://loinc.org	Fy sup(b) Ag [Presence] on Red Blood Cells
10330-9	http://loinc.org	Monocytes/100 leukocytes in Body fluid by Manual count
10331-7	http://loinc.org	Rh [Type] in Blood
10332-5	http://loinc.org	Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM
10333-3	http://loinc.org	Appearance of Cerebral spinal fluid
10334-1	http://loinc.org	Cancer Ag 125 [Units/volume] in Serum or Plasma
10335-8	http://loinc.org	Color of Cerebral spinal fluid
10336-6	http://loinc.org	Gonadotropin peptide [Mass/volume] in Urine
10337-4	http://loinc.org	Procollagen type I [Mass/volume] in Serum
10338-2	http://loinc.org	Barbiturates [Mass/volume] in Serum or Plasma
10339-0	http://loinc.org	Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma
1034-8	http://loinc.org	Fetal cell screen [Interpretation] in Blood
10340-8	http://loinc.org	Molindone [Mass/volume] in Serum or Plasma
10341-6	http://loinc.org	Norpropoxyphene [Mass/volume] in Serum or Plasma
10342-4	http://loinc.org	Sulfamethoxazole [Mass/volume] in Serum or Plasma
10343-2	http://loinc.org	Temazepam [Mass/volume] in Serum or Plasma
10344-0	http://loinc.org	Tranylcypromine [Mass/volume] in Serum or Plasma
10345-7	http://loinc.org	Trihexyphenidyl [Mass/volume] in Urine
10346-5	http://loinc.org	Hemoglobin A [Units/volume] in Blood by Electrophoresis
10347-3	http://loinc.org	Babesia microti identified in Blood by Light microscopy
10348-1	http://loinc.org	Bordetella parapertussis Ab [Presence] in Serum
10349-9	http://loinc.org	Brucella sp Ab [Units/volume] in Serum
1035-5	http://loinc.org	Fresh frozen plasma given [Volume]
10350-7	http://loinc.org	Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay
10351-5	http://loinc.org	HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
10352-3	http://loinc.org	Bacteria identified in Genital specimen by Aerobe culture
10353-1	http://loinc.org	Bacteria identified in Nose by Aerobe culture
10354-9	http://loinc.org	Bacteria identified in Urethra by Culture
10355-6	http://loinc.org	Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain
10356-4	http://loinc.org	Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain
10357-2	http://loinc.org	Microscopic observation [Identifier] in Wound by Gram stain
10358-0	http://loinc.org	Teichoate Ab [Titer] in Serum by Immune diffusion (ID)
10359-8	http://loinc.org	Asialoganglioside GM1 IgM Ab [Titer] in Serum
1036-3	http://loinc.org	G Ab [Presence] in Serum or Plasma from Blood product unit
10360-6	http://loinc.org	DNA single strand IgG Ab [Units/volume] in Serum
10361-4	http://loinc.org	DNA single strand IgM Ab [Units/volume] in Serum
10362-2	http://loinc.org	Endomysium IgA Ab [Presence] in Serum
10363-0	http://loinc.org	Barbiturates [Presence] in Unspecified specimen
10364-8	http://loinc.org	Cotinine [Mass/mass] in Hair
10365-5	http://loinc.org	Cotinine [Mass/volume] in Serum or Plasma
10366-3	http://loinc.org	Cotinine [Mass/volume] in Urine
10367-1	http://loinc.org	Ethanol [Mass/volume] in Gastric fluid
10368-9	http://loinc.org	Lead [Mass/volume] in Capillary blood
10369-7	http://loinc.org	Opiates [Mass/mass] in Hair
1037-1	http://loinc.org	G Ab [Presence] in Serum or Plasma from Donor
10370-5	http://loinc.org	Phencyclidine [Mass/mass] in Hair
10371-3	http://loinc.org	Bite cells [Presence] in Blood by Light microscopy
10372-1	http://loinc.org	Blister cells [Presence] in Blood by Light microscopy
10373-9	http://loinc.org	Fragments [Presence] in Blood by Light microscopy
10374-7	http://loinc.org	Helmet cells [Presence] in Blood by Light microscopy
10375-4	http://loinc.org	Irregularly contracted cells [Presence] in Blood by Light microscopy
10376-2	http://loinc.org	Oval macrocytes [Presence] in Blood by Light microscopy
10377-0	http://loinc.org	Pencil cells [Presence] in Blood by Light microscopy
10378-8	http://loinc.org	Polychromasia [Presence] in Blood by Light microscopy
10379-6	http://loinc.org	Erythrocytes.dual population [Presence] in Blood by Light microscopy
1038-9	http://loinc.org	G Ab [Presence] in Serum or Plasma
10380-4	http://loinc.org	Stomatocytes [Presence] in Blood by Light microscopy
10381-2	http://loinc.org	Target cells [Presence] in Blood by Light microscopy
10382-0	http://loinc.org	A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit
10383-8	http://loinc.org	A,B variant NOS Ag [Presence] on Red Blood Cells from Donor
10384-6	http://loinc.org	A,B variant NOS Ag [Presence] on Red Blood Cells
10385-3	http://loinc.org	Albumin concentration given
10386-1	http://loinc.org	Albumin given [Volume]
10387-9	http://loinc.org	Autologous erythrocytes given [Volume]
10388-7	http://loinc.org	Autologous whole blood given [Volume]
10389-5	http://loinc.org	Blood product.other [Type]
1039-7	http://loinc.org	G Ag [Presence] on Red Blood Cells from Blood product unit
10390-3	http://loinc.org	Blood product special preparation [Type]
10391-1	http://loinc.org	Cytomegalovirus immune globulin given [Volume]
10392-9	http://loinc.org	Cryoprecipitate given [Volume]
10393-7	http://loinc.org	Factor IX given [Type]
10394-5	http://loinc.org	Factor IX given [Volume]
10395-2	http://loinc.org	Factor VIII given [Type]
10396-0	http://loinc.org	Factor VIII given [Volume]
10397-8	http://loinc.org	Hepatitis B immune globulin given [Volume]
10398-6	http://loinc.org	I Ag [Presence] on Red Blood Cells from Blood product unit
10399-4	http://loinc.org	I Ag [Presence] on Red Blood Cells from Donor
104-0	http://loinc.org	Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)
1040-5	http://loinc.org	G Ag [Presence] on Red Blood Cells from Donor
10400-0	http://loinc.org	I Ag [Presence] on Red Blood Cells
10401-8	http://loinc.org	Immune serum globulin given [Type]
10402-6	http://loinc.org	Immune serum globulin given [Volume]
10403-4	http://loinc.org	Inject immune serum globulin [Volume]
10404-2	http://loinc.org	Inject Rh immune globulin [Volume]
10405-9	http://loinc.org	Inject varicella zoster virus immune globulin [Volume]
10406-7	http://loinc.org	little i Ag [Presence] on Red Blood Cells from Blood product unit
10407-5	http://loinc.org	little i Ag [Presence] on Red Blood Cells from Donor
10408-3	http://loinc.org	little i Ag [Presence] on Red Blood Cells
10409-1	http://loinc.org	Pentaspan given [Volume]
1041-3	http://loinc.org	G Ag [Presence] on Red Blood Cells
10410-9	http://loinc.org	Plasma given [Type]
10411-7	http://loinc.org	Plasma given [Volume]
10412-5	http://loinc.org	Platelets given [Type]
10413-3	http://loinc.org	Rh immune globulin given [Volume]
10414-1	http://loinc.org	Transfuse albumin [Volume]
10415-8	http://loinc.org	Transfuse blood exchange transfusion [Volume]
10416-6	http://loinc.org	Transfuse blood product other [Volume]
10417-4	http://loinc.org	Transfuse cryoprecipitate [Volume]
10418-2	http://loinc.org	Transfuse factor IX [Volume]
10419-0	http://loinc.org	Transfuse factor VIII [Volume]
1042-1	http://loinc.org	H Ab [Presence] in Serum or Plasma from Blood product unit
10420-8	http://loinc.org	Transfuse immune serum globulin [Volume]
10421-6	http://loinc.org	Transfuse Pentaspan [Volume]
10422-4	http://loinc.org	Transfuse plasma [Volume]
10423-2	http://loinc.org	Transfuse platelets [Volume]
10424-0	http://loinc.org	Transfuse erythrocytes [Volume]
10425-7	http://loinc.org	Transfuse Rh immune globulin [Volume]
10426-5	http://loinc.org	Transfuse whole blood [Volume]
10427-3	http://loinc.org	Transfuse whole blood autologous [Volume]
10428-1	http://loinc.org	Varicella zoster virus immune globulin given [Volume]
10429-9	http://loinc.org	AE 1 Ag [Presence] in Tissue by Immune stain
1043-9	http://loinc.org	H Ab [Presence] in Serum or Plasma from Donor
10430-7	http://loinc.org	AE 3 Ag [Presence] in Tissue by Immune stain
10431-5	http://loinc.org	B-cell Ag [Presence] in Tissue by Immune stain
10432-3	http://loinc.org	CD30 Ag [Presence] in Tissue by Immune stain
10433-1	http://loinc.org	BR-2 Ag [Presence] in Tissue by Immune stain
10434-9	http://loinc.org	Complement C3 Ag [Presence] in Tissue by Immune stain
10435-6	http://loinc.org	C5B-9 Ag [Presence] in Tissue by Immune stain
10436-4	http://loinc.org	CD15 Ag [Presence] in Tissue by Immune stain
10437-2	http://loinc.org	CD16 Ag [Presence] in Tissue by Immune stain
10438-0	http://loinc.org	CD20 Ag [Presence] in Tissue by Immune stain
10439-8	http://loinc.org	CD3 Ag [Presence] in Tissue by Immune stain
1044-7	http://loinc.org	H Ab [Presence] in Serum
10440-6	http://loinc.org	Deprecated CD30 Ag [Presence] in Tissue by Immune stain
10441-4	http://loinc.org	CD34 Ag [Presence] in Tissue by Immune stain
10442-2	http://loinc.org	CD56 Ag [Presence] in Tissue by Immune stain
10443-0	http://loinc.org	CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain
10444-8	http://loinc.org	CD57 Ag [Presence] in Tissue by Immune stain
10445-5	http://loinc.org	CD11c Ag [Presence] in Tissue by Immune stain
10446-3	http://loinc.org	Leukocyte common Ag [Presence] in Tissue by Immune stain
10447-1	http://loinc.org	M-5 Ag [Presence] in Tissue by Immune stain
10448-9	http://loinc.org	T-cell Ag [Presence] in Tissue by Immune stain
10449-7	http://loinc.org	Glucose [Mass/volume] in Serum or Plasma --1 hour post meal
1045-4	http://loinc.org	H NOS Ab [Presence] in Serum or Plasma from Blood product unit
10450-5	http://loinc.org	Glucose [Mass/volume] in Serum or Plasma --10 hours fasting
10451-3	http://loinc.org	Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting
10452-1	http://loinc.org	Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO
10453-9	http://loinc.org	Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO
10454-7	http://loinc.org	Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO
10455-4	http://loinc.org	Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO
10456-2	http://loinc.org	Xylose [Mass/volume] in Serum or Plasma --6 hours fasting
10457-0	http://loinc.org	Actin Ag [Presence] in Tissue by Immune stain
10458-8	http://loinc.org	Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain
10459-6	http://loinc.org	Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain
1046-2	http://loinc.org	H NOS Ab [Presence] in Serum or Plasma from Donor
10460-4	http://loinc.org	Lactalbumin alpha Ag [Presence] in Tissue by Immune stain
10461-2	http://loinc.org	Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain
10462-0	http://loinc.org	Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain
10463-8	http://loinc.org	Amyloid A component Ag [Presence] in Tissue by Immune stain
10464-6	http://loinc.org	Amyloid P component Ag [Presence] in Tissue by Immune stain
10465-3	http://loinc.org	Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain
10466-1	http://loinc.org	Anion gap 3 in Serum or Plasma
10467-9	http://loinc.org	Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain
10468-7	http://loinc.org	Calcitonin Ag [Presence] in Tissue by Immune stain
10469-5	http://loinc.org	Carcinoembryonic Ag [Presence] in Tissue by Immune stain
1047-0	http://loinc.org	H NOS Ab [Presence] in Serum or Plasma
10470-3	http://loinc.org	Choriogonadotropin Ag [Presence] in Tissue by Immune stain
10471-1	http://loinc.org	Chromogranin A Ag [Presence] in Tissue by Immune stain
10472-9	http://loinc.org	Chromogranin Ag [Presence] in Tissue by Immune stain
10473-7	http://loinc.org	Chymotrypsin Ag [Presence] in Tissue by Immune stain
10474-5	http://loinc.org	Collagen type 4 Ag [Presence] in Tissue by Immune stain
10475-2	http://loinc.org	Corticotropin Ag [Presence] in Tissue by Immune stain
10476-0	http://loinc.org	Desmin Ag [Presence] in Tissue by Immune stain
10477-8	http://loinc.org	Enolase.neuron specific Ag [Presence] in Tissue by Immune stain
10478-6	http://loinc.org	Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain
10479-4	http://loinc.org	CD227 Ag [Presence] in Tissue by Immune stain
1048-8	http://loinc.org	H NOS Ag [Presence] on Red Blood Cells from Blood product unit
10480-2	http://loinc.org	Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain
10481-0	http://loinc.org	Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain
10482-8	http://loinc.org	Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain
10483-6	http://loinc.org	Gastrin Ag [Presence] in Tissue by Immune stain
10484-4	http://loinc.org	Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain
10485-1	http://loinc.org	Glucagon Ag [Presence] in Tissue by Immune stain
10486-9	http://loinc.org	Hemoglobin Ag [Presence] in Tissue by Immune stain
10487-7	http://loinc.org	HMB-45 Ag [Presence] in Tissue by Immune stain
10488-5	http://loinc.org	IgA Ag [Presence] in Tissue by Immune stain
10489-3	http://loinc.org	IgA.heavy chain Ag [Presence] in Tissue by Immune stain
1049-6	http://loinc.org	H NOS Ag [Presence] on Red Blood Cells from Donor
10490-1	http://loinc.org	IgE Ag [Presence] in Tissue by Immune stain
10491-9	http://loinc.org	IgG Ag [Presence] in Tissue by Immune stain
10492-7	http://loinc.org	IgG.heavy chain Ag [Presence] in Tissue by Immune stain
10493-5	http://loinc.org	IgM Ag [Presence] in Tissue by Immune stain
10494-3	http://loinc.org	IgM.heavy chain Ag [Presence] in Tissue by Immune stain
10495-0	http://loinc.org	Insulin Ag [Presence] in Tissue by Immune stain
10496-8	http://loinc.org	Kappa light chains Ag [Presence] in Tissue by Immune stain
10497-6	http://loinc.org	Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain
10498-4	http://loinc.org	Keratin Ag [Presence] in Tissue by Immune stain
10499-2	http://loinc.org	Lambda light chains Ag [Presence] in Tissue by Immune stain
105-7	http://loinc.org	Ceforanide [Susceptibility] by Disk diffusion (KB)
1050-4	http://loinc.org	H NOS Ag [Presence] on Red Blood Cells
10500-7	http://loinc.org	Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain
10501-5	http://loinc.org	Lutropin [Units/volume] in Serum or Plasma
10502-3	http://loinc.org	Lutropin Ag [Presence] in Tissue by Immune stain
10503-1	http://loinc.org	Lysozyme Ag [Presence] in Tissue by Immune stain
10504-9	http://loinc.org	Myelin basic protein Ag [Presence] in Tissue by Immune stain
10505-6	http://loinc.org	Myoglobin Ag [Presence] in Tissue by Immune stain
10506-4	http://loinc.org	Peanut agglutinin Ag [Presence] in Tissue by Immune stain
10507-2	http://loinc.org	Prolactin Ag [Presence] in Tissue by Immune stain
10508-0	http://loinc.org	Prostate specific Ag [Presence] in Tissue by Immune stain
10509-8	http://loinc.org	Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain
1051-2	http://loinc.org	Hemolytic disease of newborn screen [Interpretation] in Blood
10510-6	http://loinc.org	S-100 Ag Ag [Presence] in Tissue by Immune stain
10511-4	http://loinc.org	Serotonin Ag [Presence] in Tissue by Immune stain
10512-2	http://loinc.org	Somatostatin Ag [Presence] in Tissue by Immune stain
10513-0	http://loinc.org	Somatotropin Ag [Presence] in Tissue by Immune stain
10514-8	http://loinc.org	Synaptophysin Ag [Presence] in Tissue by Immune stain
10515-5	http://loinc.org	Thyroglobulin Ag [Presence] in Tissue by Immune stain
10516-3	http://loinc.org	Thyrotropin Ag [Presence] in Tissue by Immune stain
10517-1	http://loinc.org	Trypsin Ag [Presence] in Tissue by Immune stain
10518-9	http://loinc.org	Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain
10519-7	http://loinc.org	Vimentin Ag [Presence] in Tissue by Immune stain
1052-0	http://loinc.org	Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit
10520-5	http://loinc.org	Coagulation factor VI Ag [Presence] in Tissue by Immune stain
10521-3	http://loinc.org	Coagulation factor VIII Ag [Presence] in Tissue by Immune stain
10522-1	http://loinc.org	Coagulation factor XIII Ag [Presence] in Tissue by Immune stain
10523-9	http://loinc.org	Fibrinogen Ag [Presence] in Tissue by Immune stain
10524-7	http://loinc.org	Microscopic observation [Identifier] in Cervix by Cyto stain
10525-4	http://loinc.org	Microscopic observation [Identifier] in Unspecified specimen by Cyto stain
10526-2	http://loinc.org	Microscopic observation [Identifier] in Sputum by Cyto stain
10527-0	http://loinc.org	Microscopic observation [Identifier] in Tissue by Cyto stain
10528-8	http://loinc.org	Acetophenazine [Mass/volume] in Serum or Plasma
10529-6	http://loinc.org	Amoxapine metabolite [Mass/volume] in Serum or Plasma
1053-8	http://loinc.org	Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor
10530-4	http://loinc.org	Aprobarbital [Mass/volume] in Serum or Plasma
10531-2	http://loinc.org	Bretylium [Mass/volume] in Serum or Plasma
10532-0	http://loinc.org	Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma
10533-8	http://loinc.org	Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma
10534-6	http://loinc.org	Diazoxide [Mass/volume] in Serum or Plasma
10535-3	http://loinc.org	Digoxin [Mass/volume] in Serum or Plasma
10536-1	http://loinc.org	Dipyridamole [Mass/volume] in Serum or Plasma
10537-9	http://loinc.org	Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma
10538-7	http://loinc.org	Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma
10539-5	http://loinc.org	Glipizide [Mass/volume] in Serum or Plasma
1054-6	http://loinc.org	Deprecated I (intermediate) subtype [Presence] in srum
10540-3	http://loinc.org	Glyburide [Mass/volume] in Serum or Plasma
10541-1	http://loinc.org	Mepivacaine [Mass/volume] in Serum or Plasma
10542-9	http://loinc.org	Metharbital [Mass/volume] in Serum or Plasma
10543-7	http://loinc.org	Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma
10544-5	http://loinc.org	Normeperidine [Presence] in Serum or Plasma
10545-2	http://loinc.org	Normephenytoin [Mass/volume] in Serum or Plasma
10546-0	http://loinc.org	Normethsuximide [Mass/volume] in Serum or Plasma
10547-8	http://loinc.org	Primidone+Phenobarbital [Mass/volume] in Serum or Plasma
10548-6	http://loinc.org	Phenytoin Free/Phenytoin.total in Serum or Plasma
10549-4	http://loinc.org	Pirmenol [Mass/volume] in Serum or Plasma
1055-3	http://loinc.org	Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit
10550-2	http://loinc.org	Deprecated Temazepam [Mass/volume] in Serum or Plasma
10551-0	http://loinc.org	Triamterene [Mass/volume] in Serum or Plasma
10552-8	http://loinc.org	Tricyclic antidepressants [Mass/volume] in Serum or Plasma
10553-6	http://loinc.org	Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid
10554-4	http://loinc.org	Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma
10555-1	http://loinc.org	Acrosin [Entitic Catalytic Activity] in Spermatozoa
10556-9	http://loinc.org	Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma
10557-7	http://loinc.org	Adenosine triphosphate [Moles/volume] in Semen
10558-5	http://loinc.org	Albumin [Moles/volume] in Semen
10559-3	http://loinc.org	Deprecated Calcium [Molecules/volume] in Semen
1056-1	http://loinc.org	Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor
10560-1	http://loinc.org	Carcinoembryonic Ag [Units/volume] in Semen
10561-9	http://loinc.org	Carnitine [Moles/volume] in Semen
10562-7	http://loinc.org	Cells [#/volume] in Cervical mucus
10563-5	http://loinc.org	Cells other than spermatozoa [#/volume] in Semen
10564-3	http://loinc.org	Cervical mucus [Volume]
10565-0	http://loinc.org	Choriogonadotropin [Units/volume] in Semen
10566-8	http://loinc.org	Deprecated Choriogonadotropin [Molecules/volume] in Semen
10567-6	http://loinc.org	Citrate [Moles/volume] in Semen
10568-4	http://loinc.org	Clarity of Semen
10569-2	http://loinc.org	Color of Semen
1057-9	http://loinc.org	Deprecated I (intermediate) subtype [Presence] on Red Blood Cells
10570-0	http://loinc.org	Consistency of Cervical mucus
10571-8	http://loinc.org	Deprecated Consistency of Semen
10572-6	http://loinc.org	Deprecated Duration^post ejaculation
10573-4	http://loinc.org	Ferning [Type] in Cervical mucus
10574-2	http://loinc.org	Fructose [Moles/volume] in Semen
10575-9	http://loinc.org	Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen
10576-7	http://loinc.org	Germ cells.immature [#/volume] in Semen
10577-5	http://loinc.org	Glucosidase [Enzymatic activity/volume] in Seminal plasma
10578-3	http://loinc.org	Glycerophosphocholine [Moles/volume] in Seminal plasma
10579-1	http://loinc.org	Leukocytes [#/volume] in Semen
1058-7	http://loinc.org	I Ab [Presence] in Serum or Plasma from Blood product unit
10580-9	http://loinc.org	Liquefaction [Time] in Semen
10581-7	http://loinc.org	Deprecated Number of entities [#] in Spermatozoa
10582-5	http://loinc.org	pH of Cervical mucus
10583-3	http://loinc.org	Prostaglandin F1 alpha [Moles/volume] in Semen
10584-1	http://loinc.org	Deprecated Protein [Mass/volume] in Semen
10585-8	http://loinc.org	Round cells [#/volume] in Semen
10586-6	http://loinc.org	Deprecated Volume of Semen
10587-4	http://loinc.org	Sexual abstinence duration
10588-2	http://loinc.org	Spermatogonia [#/volume] in Semen
10589-0	http://loinc.org	Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB)
1059-5	http://loinc.org	I Ab [Presence] in Serum or Plasma from Donor
10590-8	http://loinc.org	Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB)
10591-6	http://loinc.org	Primary Spermatocytes [#/volume] in Semen
10592-4	http://loinc.org	Secondary Spermatocytes [#/volume] in Semen
10593-2	http://loinc.org	Spermatozoa Pyriform Head/100 spermatozoa in Semen
10594-0	http://loinc.org	Spermatozoa Tapering Head/100 spermatozoa in Semen
10595-7	http://loinc.org	Deprecated Spermatozoa [#/volume] in Semen
10596-5	http://loinc.org	Deprecated Spermatozoa Ab in cervical mucosa
10597-3	http://loinc.org	Deprecated Spermatozoa Ab in semen
10598-1	http://loinc.org	Deprecated Spermatozoa Ab in serum
10599-9	http://loinc.org	Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test
106-5	http://loinc.org	Ceforanide [Susceptibility] by Serum bactericidal titer
1060-3	http://loinc.org	I Ab [Presence] in Serum or Plasma
10600-5	http://loinc.org	Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa
10601-3	http://loinc.org	Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus
10602-1	http://loinc.org	Spermatozoa Abnormal Head/100 spermatozoa in Semen
10603-9	http://loinc.org	Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen
10604-7	http://loinc.org	Spermatozoa Abnormal Tail/100 spermatozoa in Semen
10605-4	http://loinc.org	Spermatozoa Agglutinated/100 spermatozoa in Semen
10606-2	http://loinc.org	Spermatozoa Amorphous Head/100 spermatozoa in Semen
10607-0	http://loinc.org	Spermatozoa Coiled Tail/100 spermatozoa in Semen
10608-8	http://loinc.org	Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen
10609-6	http://loinc.org	Spermatozoa Duplicate Head/100 spermatozoa in Semen
1061-1	http://loinc.org	I NOS Ab [Presence] in Serum or Plasma from Blood product unit
10610-4	http://loinc.org	Spermatozoa Duplicate Tail/100 spermatozoa in Semen
10611-2	http://loinc.org	Spermatozoa Immotile/100 spermatozoa in Semen
10612-0	http://loinc.org	Spermatozoa Large Oval Head/100 spermatozoa in Semen
10613-8	http://loinc.org	Spermatozoa Viable/100 spermatozoa in Semen
10614-6	http://loinc.org	Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead
10615-3	http://loinc.org	Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction
10616-1	http://loinc.org	Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead
10617-9	http://loinc.org	Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction
10618-7	http://loinc.org	Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead
10619-5	http://loinc.org	Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction
1062-9	http://loinc.org	I NOS Ab [Presence] in Serum or Plasma from Donor
10620-3	http://loinc.org	Spermatozoa Nonprogressive/100 spermatozoa in Semen
10621-1	http://loinc.org	Spermatozoa Normal Head/100 spermatozoa in Semen
10622-9	http://loinc.org	Spermatozoa Normal/100 spermatozoa in Semen
10623-7	http://loinc.org	Spermatozoa Pin Head/100 spermatozoa in Semen
10624-5	http://loinc.org	Spermatozoa Rapid/100 spermatozoa in Semen
10625-2	http://loinc.org	Spermatozoa Round Head/100 spermatozoa in Semen
10626-0	http://loinc.org	Spermatozoa Slow/100 spermatozoa in Semen
10627-8	http://loinc.org	Spermatozoa Small Oval Head/100 spermatozoa in Semen
10628-6	http://loinc.org	Spermatozoa Tail Swelling/100 spermatozoa in Semen
10629-4	http://loinc.org	Spermatozoa Vacuolated Head/100 spermatozoa in Semen
1063-7	http://loinc.org	I NOS Ab [Presence] in Serum or Plasma
10630-2	http://loinc.org	Spinnbarkeit [Length] in Cervical mucus
10631-0	http://loinc.org	Testosterone [Moles/volume] in Semen
10632-8	http://loinc.org	Time until next menstrual period
10633-6	http://loinc.org	Zinc [Moles/volume] in Semen
10634-4	http://loinc.org	Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
10635-1	http://loinc.org	Acanthamoeba sp identified in Eye by Organism specific culture
10636-9	http://loinc.org	Acanthamoeba sp identified in Eye by Wet preparation
10637-7	http://loinc.org	Microscopic observation [Identifier] in Tissue by Night blue stain
10638-5	http://loinc.org	Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture
10639-3	http://loinc.org	Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture
1064-5	http://loinc.org	I NOS Ag [Presence] on Red Blood Cells from Blood product unit
10640-1	http://loinc.org	Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy
10641-9	http://loinc.org	Amoeba identified in Aspirate by Immune stain
10642-7	http://loinc.org	Amoeba identified in Aspirate by Wet preparation
10643-5	http://loinc.org	Amoeba identified in Stool by Organism specific culture
10644-3	http://loinc.org	Arthropod identified in Unspecified specimen
10645-0	http://loinc.org	Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence
10646-8	http://loinc.org	Astrovirus [Identifier] in Stool by Electron microscopy
10647-6	http://loinc.org	Babesia sp identified in Blood by Thick film
10648-4	http://loinc.org	Babesia sp identified in Blood by Thin film
10649-2	http://loinc.org	Calicivirus [Identifier] in Stool by Electron microscopy
1065-2	http://loinc.org	I NOS Ag [Presence] on Red Blood Cells from Donor
10650-0	http://loinc.org	Candida sp DNA [Presence] in Blood by Probe with amplification
10651-8	http://loinc.org	Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial
10652-6	http://loinc.org	Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification
10653-4	http://loinc.org	Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)
10654-2	http://loinc.org	Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)
10655-9	http://loinc.org	Coccidia identified in Duodenal fluid by Acid fast stain
10656-7	http://loinc.org	Coccidia identified in Stool by Acid fast stain
10657-5	http://loinc.org	Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence
10658-3	http://loinc.org	Cyanobacterium identified in Water by Light microscopy
10659-1	http://loinc.org	Cyclospora sp identified in Stool by Acid fast stain
1066-0	http://loinc.org	I NOS Ag [Presence] on Red Blood Cells
10660-9	http://loinc.org	Cytomegalovirus Ag [Presence] in Tissue by Immune stain
10661-7	http://loinc.org	Dinoflagellate identified in Water by Light microscopy
10662-5	http://loinc.org	Filaria identified in Blood by Concentration
10663-3	http://loinc.org	Filaria identified in Blood by Thick film
10664-1	http://loinc.org	Filaria identified in Blood by Thin film
10665-8	http://loinc.org	Fungus colony count [#/volume] in Unspecified specimen by Environmental culture
10666-6	http://loinc.org	Fungus identified in Tissue by Fontana-Masson stain
10667-4	http://loinc.org	Fungus identified in Unspecified specimen by Animal inoculation
10668-2	http://loinc.org	Fungus identified in Unspecified specimen by Environmental culture
10669-0	http://loinc.org	Fungus identified in Unspecified specimen by Sticky tape for environmental fungus
1067-8	http://loinc.org	Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
10670-8	http://loinc.org	Giardia lamblia [Presence] in Stool by Organism specific culture
10671-6	http://loinc.org	Helminth identified in Unspecified specimen
10672-4	http://loinc.org	Helminth+Arthropod identified in Unspecified specimen
10673-2	http://loinc.org	Hepatitis B virus core Ag [Presence] in Tissue by Immune stain
10674-0	http://loinc.org	Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain
10675-7	http://loinc.org	Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain
10676-5	http://loinc.org	Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
10677-3	http://loinc.org	Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain
10678-1	http://loinc.org	Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain
10679-9	http://loinc.org	Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain
1068-6	http://loinc.org	Jk sup(a) Ab [Presence] in Serum or Plasma from Donor
10680-7	http://loinc.org	Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy
10681-5	http://loinc.org	Herpes simplex virus identified in Tissue by Electron microscopy
10682-3	http://loinc.org	Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification
10683-1	http://loinc.org	Hydatid cyst identified in Aspirate by Immune stain
10684-9	http://loinc.org	Hydatid cyst identified in Liver by Wet preparation
10685-6	http://loinc.org	Hydatid cyst identified in Lung tissue by Wet preparation
10686-4	http://loinc.org	Leishmania sp identified in Tissue by Giemsa stain
10687-2	http://loinc.org	Leishmania sp identified in Tissue by Organism specific culture
10688-0	http://loinc.org	Microscopic observation [Identifier] in Hair by KOH preparation
10689-8	http://loinc.org	Microscopic observation [Identifier] in Nail by KOH preparation
1069-4	http://loinc.org	Jk sup(a) Ab [Presence] in Serum or Plasma
10690-6	http://loinc.org	Microsporidia identified in Duodenal fluid by Trichrome stain modified
10691-4	http://loinc.org	Mushroom.toxic identified by Inspection
10692-2	http://loinc.org	Mushroom.toxic identified in Food by Light microscopy
10693-0	http://loinc.org	Mushroom.toxic identified in Vomitus by Light microscopy
10694-8	http://loinc.org	Naegleria sp identified in Tissue by Organism specific culture
10695-5	http://loinc.org	Naegleria sp identified in Tissue by Wet preparation
10696-3	http://loinc.org	Norovirus [Identifier] in Stool by Electron microscopy
10697-1	http://loinc.org	Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)
10698-9	http://loinc.org	Nystatin [Susceptibility] by Minimum lethal concentration (MLC)
10699-7	http://loinc.org	Onchocerca sp identified in Tissue by Wet preparation
107-3	http://loinc.org	Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)
1070-2	http://loinc.org	Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
10700-3	http://loinc.org	Orthopoxvirus [Identifier] in Skin by Electron microscopy
10701-1	http://loinc.org	Ova and parasites identified in Stool by Concentration
10702-9	http://loinc.org	Ova and parasites identified in Stool by Immune stain
10703-7	http://loinc.org	Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain
10704-5	http://loinc.org	Ova and parasites identified in Stool by Light microscopy
10705-2	http://loinc.org	Human papilloma virus Ag [Presence] in Tissue by Immune stain
10706-0	http://loinc.org	Picornavirus [Identifier] in Stool by Electron microscopy
10707-8	http://loinc.org	Toxic Plant identified in Plant specimen by Inspection
10708-6	http://loinc.org	Toxic Plant identified in Vomitus by Light microscopy
10709-4	http://loinc.org	Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence
1071-0	http://loinc.org	Jk sup(a) Ag [Presence] on Red Blood Cells from Donor
10710-2	http://loinc.org	Plasmodium sp identified in Blood by Thin film
10711-0	http://loinc.org	Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence
10712-8	http://loinc.org	Pneumocystis sp identified in Lung tissue
10713-6	http://loinc.org	Prototheca identified in Unspecified specimen by Culture
10714-4	http://loinc.org	Deprecated Rotavirus [Identifier] in Stool by Electron microscopy
10715-1	http://loinc.org	Schistosoma sp identified in Urine sediment by Light microscopy
10716-9	http://loinc.org	Schistosoma sp identified in Unspecified specimen by Organism specific culture
10717-7	http://loinc.org	Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination
10718-5	http://loinc.org	Strongyloides sp Ab [Units/volume] in Serum by Immunoassay
10719-3	http://loinc.org	Taenia solium adult Ab [Units/volume] in Serum by Immunoblot
1072-8	http://loinc.org	Jk sup(a) Ag [Presence] on Red Blood Cells
10720-1	http://loinc.org	Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)
10721-9	http://loinc.org	Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)
10722-7	http://loinc.org	Torovirus [Identifier] in Stool by Electron microscopy
10723-5	http://loinc.org	Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay
10724-3	http://loinc.org	Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay
10725-0	http://loinc.org	Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification
10726-8	http://loinc.org	Toxoplasma gondii [Presence] in Tissue by Giemsa stain
10727-6	http://loinc.org	Toxoplasma gondii identified in Tissue
10728-4	http://loinc.org	Trichomonas sp identified in Genital specimen by Organism specific culture
10729-2	http://loinc.org	Trypanosoma sp identified in Blood by Light microscopy
1073-6	http://loinc.org	Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
10730-0	http://loinc.org	Trypanosoma sp identified in Blood by Organism specific culture
10731-8	http://loinc.org	Trypanosoma sp identified in Blood by Thick film
10732-6	http://loinc.org	Trypanosoma sp identified in Blood by Thin film
10733-4	http://loinc.org	Trypanosoma sp identified in Blood by Wet preparation
10734-2	http://loinc.org	Varicella zoster virus identified in Skin by Electron microscopy
10735-9	http://loinc.org	Viral sequencing [Identifier] in Serum by Sequencing
10736-7	http://loinc.org	Virus identified in Cerebral spinal fluid by Electron microscopy
10737-5	http://loinc.org	Virus identified in Stool by Electron microscopy
10738-3	http://loinc.org	Virus identified in Tissue by Electron microscopy
10739-1	http://loinc.org	Virus identified in Unspecified specimen by Electron microscopy
1074-4	http://loinc.org	Jk sup(b) Ab [Presence] in Serum or Plasma from Donor
10740-9	http://loinc.org	Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain
10741-7	http://loinc.org	Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain
10742-5	http://loinc.org	Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified
10743-3	http://loinc.org	Amyloid.microscopic observation [Identifier] in Tissue by Highman stain
10744-1	http://loinc.org	Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain
10745-8	http://loinc.org	Bile.microscopic observation [Identifier] in Tissue by Fouchet stain
10746-6	http://loinc.org	Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain
10747-4	http://loinc.org	Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain
10748-2	http://loinc.org	Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain
10749-0	http://loinc.org	Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain
1075-1	http://loinc.org	Jk sup(b) Ab [Presence] in Serum or Plasma
10750-8	http://loinc.org	Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson
10751-6	http://loinc.org	Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain
10752-4	http://loinc.org	Fat.microscopic observation [Identifier] in Milk by Sudan IV stain
10753-2	http://loinc.org	Fat.microscopic observation [Identifier] in Stool by Sudan IV stain
10754-0	http://loinc.org	Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain
10755-7	http://loinc.org	Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott
10756-5	http://loinc.org	Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain
10757-3	http://loinc.org	Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald
10758-1	http://loinc.org	Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain
10759-9	http://loinc.org	Iron.microscopic observation [Identifier] in Sputum by Gomori stain
1076-9	http://loinc.org	Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
10760-7	http://loinc.org	Iron.microscopic observation [Identifier] in Tissue by Gomori stain
10761-5	http://loinc.org	Iron.microscopic observation [Identifier] in Tissue by Other stain
10762-3	http://loinc.org	Microscopic observation [Identifier] in Blood by Hemosiderin stain
10763-1	http://loinc.org	Microscopic observation [Identifier] in Body fluid by Sudan black stain
10764-9	http://loinc.org	Microscopic observation [Identifier] in Sputum by Silver stain
10765-6	http://loinc.org	Microscopic observation [Identifier] in Tissue by Acetate esterase stain
10766-4	http://loinc.org	Microscopic observation [Identifier] in Tissue by Alcian blue stain
10767-2	http://loinc.org	Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated
10768-0	http://loinc.org	Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff
10769-8	http://loinc.org	Microscopic observation [Identifier] in Tissue by Alizarin red S stain
1077-7	http://loinc.org	Jk sup(b) Ag [Presence] on Red Blood Cells from Donor
10770-6	http://loinc.org	Microscopic observation [Identifier] in Tissue by Argentaffin stain
10771-4	http://loinc.org	Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain
10772-2	http://loinc.org	Microscopic observation [Identifier] in Tissue by Azure-eosin stain
10773-0	http://loinc.org	Microscopic observation [Identifier] in Tissue by Basic fuchsin stain
10774-8	http://loinc.org	Microscopic observation [Identifier] in Tissue by Bielschowsky stain
10775-5	http://loinc.org	Microscopic observation [Identifier] in Tissue by Bleach stain
10776-3	http://loinc.org	Microscopic observation [Identifier] in Tissue by Bodian stain
10777-1	http://loinc.org	Microscopic observation [Identifier] in Tissue by Brown and Brenn stain
10778-9	http://loinc.org	Microscopic observation [Identifier] in Tissue by Butyrate esterase stain
10779-7	http://loinc.org	Microscopic observation [Identifier] in Tissue by Carmine stain.Best
1078-5	http://loinc.org	Jk sup(b) Ag [Presence] on Red Blood Cells
10780-5	http://loinc.org	Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain
10781-3	http://loinc.org	Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain
10782-1	http://loinc.org	Microscopic observation [Identifier] in Tissue by Congo red stain
10783-9	http://loinc.org	Microscopic observation [Identifier] in Tissue by Crystal violet stain
10784-7	http://loinc.org	Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific
10785-4	http://loinc.org	Microscopic observation [Identifier] in Tissue by Fite-Faraco stain
10786-2	http://loinc.org	Deprecated Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron
10787-0	http://loinc.org	Microscopic observation [Identifier] in Tissue by Gridley stain
10788-8	http://loinc.org	Microscopic observation [Identifier] in Tissue by Hansel stain
10789-6	http://loinc.org	Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain
1079-3	http://loinc.org	Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
10790-4	http://loinc.org	Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain
10791-2	http://loinc.org	Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain
10792-0	http://loinc.org	Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones
10793-8	http://loinc.org	Microscopic observation [Identifier] in Tissue by Methyl green stain
10794-6	http://loinc.org	Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain
10795-3	http://loinc.org	Microscopic observation [Identifier] in Tissue by Methyl violet stain
10796-1	http://loinc.org	Microscopic observation [Identifier] in Tissue by Mucicarmine stain
10797-9	http://loinc.org	Microscopic observation [Identifier] in Tissue by Neutral red stain
10798-7	http://loinc.org	Microscopic observation [Identifier] in Tissue by Oil red O stain
10799-5	http://loinc.org	Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat
108-1	http://loinc.org	Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)
1080-1	http://loinc.org	Js sup(a) Ab [Presence] in Serum or Plasma from Donor
10800-1	http://loinc.org	Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion
10801-9	http://loinc.org	Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain
10802-7	http://loinc.org	Microscopic observation [Identifier] in Tissue by Prussian blue stain
10803-5	http://loinc.org	Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain
10804-3	http://loinc.org	Microscopic observation [Identifier] in Tissue by Reticulin stain
10805-0	http://loinc.org	Microscopic observation [Identifier] in Tissue by Safranin stain
10806-8	http://loinc.org	Microscopic observation [Identifier] in Tissue by Schmorl stain
10807-6	http://loinc.org	Microscopic observation [Identifier] in Tissue by Sevier-Munger stain
10808-4	http://loinc.org	Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle
10809-2	http://loinc.org	Microscopic observation [Identifier] in Tissue by Silver nitrate stain
1081-9	http://loinc.org	Js sup(a) Ab [Presence] in Serum or Plasma
10810-0	http://loinc.org	Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson
10811-8	http://loinc.org	Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius
10812-6	http://loinc.org	Microscopic observation [Identifier] in Tissue by Steiner stain
10813-4	http://loinc.org	Microscopic observation [Identifier] in Tissue by Sudan black stain
10814-2	http://loinc.org	Microscopic observation [Identifier] in Tissue by Supravital stain
10815-9	http://loinc.org	Microscopic observation [Identifier] in Tissue by Tetrachrome stain
10816-7	http://loinc.org	Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain
10817-5	http://loinc.org	Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley
10818-3	http://loinc.org	Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified
10819-1	http://loinc.org	Microscopic observation [Identifier] in Tissue by Wade stain
1082-7	http://loinc.org	Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
10820-9	http://loinc.org	Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain
10821-7	http://loinc.org	Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain
10822-5	http://loinc.org	Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer
10823-3	http://loinc.org	Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale
10824-1	http://loinc.org	Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain
10825-8	http://loinc.org	Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain
10826-6	http://loinc.org	Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain
10827-4	http://loinc.org	Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain
10828-2	http://loinc.org	Urate crystals.microscopic observation [type] in Tissue by De Galantha stain
10829-0	http://loinc.org	Silicon [Mass/volume] in Serum or Plasma
1083-5	http://loinc.org	Js sup(a) Ag [Presence] on Red Blood Cells from Donor
10830-8	http://loinc.org	Deprecated Surgical operation note complications
10831-6	http://loinc.org	Surgical operation note complications [Interpretation]
10832-4	http://loinc.org	Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO
10833-2	http://loinc.org	Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO
10834-0	http://loinc.org	Globulin [Mass/volume] in Serum by calculation
10835-7	http://loinc.org	Lipoprotein a [Mass/volume] in Serum or Plasma
10836-5	http://loinc.org	Niacin [Mass/volume] in Blood
10837-3	http://loinc.org	Organic acids [Presence] in Serum or Plasma
10838-1	http://loinc.org	Phosphoserine [Mass/volume] in Serum or Plasma
10839-9	http://loinc.org	Troponin I.cardiac [Mass/volume] in Serum or Plasma
1084-3	http://loinc.org	Js sup(a) Ag [Presence] on Red Blood Cells
10840-7	http://loinc.org	Atropine [Mass/volume] in Urine
10841-5	http://loinc.org	Methazolamide [Mass/volume] in Serum or Plasma
10842-3	http://loinc.org	Deprecated HLA-DQ1 [Presence]
10843-1	http://loinc.org	Deprecated HLA-DQ2 [Presence]
10844-9	http://loinc.org	Deprecated HLA-DQ3 [Presence]
10845-6	http://loinc.org	Deprecated HLA-DQ4 [Presence]
10846-4	http://loinc.org	Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification
10847-2	http://loinc.org	Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification
10848-0	http://loinc.org	Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence
10849-8	http://loinc.org	Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence
1085-0	http://loinc.org	Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
10850-6	http://loinc.org	Cyclospora cayetanensis [Presence] in Unspecified specimen
10851-4	http://loinc.org	Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture
10852-2	http://loinc.org	Deprecated Fungus identified in Blood by Culture
10853-0	http://loinc.org	Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified
10854-8	http://loinc.org	Deprecated Midrofilaria identified in Blood by Concentration
10855-5	http://loinc.org	Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy
10856-3	http://loinc.org	Microscopic observation [Identifier] in Genital mucus by Gram stain
10857-1	http://loinc.org	Microsporidia identified in Unspecified specimen by Light microscopy
10858-9	http://loinc.org	Teichoate Ab [Presence] in Serum
10859-7	http://loinc.org	Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain
1086-8	http://loinc.org	Js sup(b) Ab [Presence] in Serum or Plasma from Donor
10860-5	http://loinc.org	Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture
10861-3	http://loinc.org	Progesterone receptor [Mass/mass] in Tissue
10862-1	http://loinc.org	Basement membrane Ab [Titer] in Serum
10863-9	http://loinc.org	Endomysium IgA Ab [Titer] in Serum
10864-7	http://loinc.org	Immune complex [Units/volume] in Serum or Plasma by Raji cell assay
10865-4	http://loinc.org	Intercellular substance Ab [Presence] in Serum
10866-2	http://loinc.org	Sulfatide IgG Ab [Titer] in Serum
10867-0	http://loinc.org	Sulfatide IgM Ab [Titer] in Serum
10868-8	http://loinc.org	Bacitracin [Susceptibility] by Disk diffusion (KB)
10869-6	http://loinc.org	Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO
1087-6	http://loinc.org	Js sup(b) Ab [Presence] in Serum or Plasma
10870-4	http://loinc.org	Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO
10871-2	http://loinc.org	Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO
10872-0	http://loinc.org	Xylose [Mass/volume] in Blood --baseline
10873-8	http://loinc.org	Beta-2-Microglobulin [Mass/time] in 24 hour Urine
10874-6	http://loinc.org	Bombesin [Mass/volume] in Plasma
10875-3	http://loinc.org	Carnitine esters [Mass/volume] in Urine
10876-1	http://loinc.org	Carnitine esters [Mass/volume] in Serum or Plasma
10877-9	http://loinc.org	Carnitine free (C0) [Mass/volume] in Urine
10878-7	http://loinc.org	Iodine.protein bound [Mass/volume] in Serum or Plasma
10879-5	http://loinc.org	Isovalerylglycine [Mass/volume] in Urine
1088-4	http://loinc.org	Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
10880-3	http://loinc.org	Magnesium [Mass/mass] in Stool
10881-1	http://loinc.org	Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells
10882-9	http://loinc.org	Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma
10883-7	http://loinc.org	Phenolphthalein [Mass/mass] in Stool
10884-5	http://loinc.org	Phosphate [Mass/mass] in Stool
10885-2	http://loinc.org	Porphyrins [Mass/time] in 24 hour Urine
10886-0	http://loinc.org	Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10887-8	http://loinc.org	Pyridinoline [Mass/time] in 24 hour Urine
10888-6	http://loinc.org	Lipase [Enzymatic activity/volume] in Urine
10889-4	http://loinc.org	Bisacodyl [Mass/mass] in Stool
1089-2	http://loinc.org	Js sup(b) Ag [Presence] on Red Blood Cells from Donor
10890-2	http://loinc.org	Deprecated Normethsuximide [Mass/volume] in Serum or Plasma
10891-0	http://loinc.org	Oxyphenisatin [Mass/mass] in Stool
10892-8	http://loinc.org	Pentoxifylline [Mass/volume] in Serum or Plasma
10893-6	http://loinc.org	Trenbolone [Mass/volume] in Urine
10894-4	http://loinc.org	Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID)
10895-1	http://loinc.org	Clostridium difficile toxin B [Presence] in Stool
10896-9	http://loinc.org	Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence
10897-7	http://loinc.org	Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
10898-5	http://loinc.org	Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence